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White Spot Syndrome Virus, Nimaviridiae Whispovirus, is one of the 
major viral pathogens in the aquaculture industry responsible for high mortality in 
cultured shrimp. The infection mechanisms of WSSV have not been fully 
characterized at the molecular level due to the large size and uniqueness of its 
genome. This study was undertaken to advance our understanding of the specific 
function of RING-containing proteins in viral pathogenesis. 
A preliminary search for regulatory protein candidates in WSSV using 
functional domain determination identified four predicted viral proteins containing 
a RING-H2 domain. Among them, the three proteins WSSV222, WSSV249 and 
WSSV403 can be expressed in both E.coli and insect cells, suggesting their 
potential expression in shrimp. In this study, emphasis has been placed on the 
characterization of WSSV222 and WSSV403. 
WSSV222 exhibits RING-H2-dependent E3 ligase activity in vitro in the 
presence of the conjugating enzyme UbcH6. Mutations in the RING-H2 domain 
abolished WSSV222-dependent ubiquitination, displaying the importance of this 
domain. Yeast two-hybrid and pull-down analyses revealed that WSSV222 
interacts with a shrimp tumor suppressor-like protein (TSL) sharing 60% identity 
with human OVCA1. 
A stable TSL-expressing cell line derived from the human ovarian cancer 
cell line A2780 was established, where a TSL-dependent prolonged G1 phase was 
observed. Based on this, WSSV222-mediated ubiquitination and MG132-sensitive 
degradation of TSL were detected both in the TSL-expressing cell line and in 
shrimp primary cell culture. Transient expression of TSL in BHK cells leads to 
apoptosis, which was rescued by the coexpression of WSSV222. Taken together, 
 II
these data suggest that WSSV222 acts as an anti-apoptosis protein by ubiquitin-
mediated proteolysis of TSL to ensure successful WSSV replication in shrimp. 
Overexpression of WSSV222 in SF9 and BHK cells could be silenced by 
specific anti-WSSV222 siRNA. Further, WSSV-challenged shrimp were treated 
with the anti-222 siRNA to knockdown WSSV222. The survival rate and the 
efficiency of WSSV replication were assessed to evaluate the efficacy of anti-222 
siRNA to inhibit WSSV infection in shrimp. The anti-222 siRNA reduced the 
cumulative mortality in shrimp challenged with 103 copies of WSSV and delayed 
the mean time to death in shrimp challenged with the higher dosage of 106 copies. 
The results of real time quantitative PCR showed that virus replication was 
delayed and reduced in the WSSV-challenged shrimp treated with anti-222 siRNA 
in comparison to the challenged shrimp treated with random siRNA. Co-
immunoprecipitation assays revealed that WSSV222 silencing inhibited the 
degradation of TSL in WSSV-challenged shrimp. These results indicate that 
WSSV222 is required for efficient replication of WSSV in shrimp. 
WSSV403 acts as a viral E3 ligase which can ubiquitinate itself in vitro in 
the presence of an E2 conjugating enzyme from shrimp. WSSV403 can be 
activated by a series of E2 variants. In RT-PCR and real time PCR, the 
transcription of WSSV403 was detected in specific-pathogen-free shrimp, 
suggesting its role as a latency-associated gene. Identified in yeast two-hybrid and 
verified by pull-down assays, WSSV403 is able to bind to a shrimp protein 
phosphatase, an interaction partner for another latent protein WSSV427. This 
study suggests that WSSV403 could be a regulator of latency state of WSSV by 
virtue of its E3 ligase function.  
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In summary, the studies presented here indicate that viral RING proteins 
are involved in ubiquitination events and interactions with a diverse range of 
shrimp proteins and play important roles as regulators of virus replication. 
In order to establish an effcient viral protein expression system, efforts 
have been made in the studies on WSSV immediate-early promoter one (IE1). The 
production of H5 HA of influenza virus by baculovirus was enhanced with WSSV 
IE1 promoter, especially compared with CMV promoter. This contributed to 
effective elicitation of HA-specific antibody in vaccinated chickens. This study 
provides an alternative choice for baculovirus based vaccine production. 
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1.1 WSSV and its host range 
White spot syndrome virus (WSSV) is one of the major pathogens in the 
aquaculture industry, leading to massive mortality and major production losses in 
cultured shrimps (Escobedo-Bonilla et al., 2008). Shrimp aquaculture has become an 
important industry worldwide during the last few decades. Intensive cultivation and 
worldwide trade of shrimp and other aquaculture products have led to the emergence 
and spread of this viral pathogen in crustaceans (Corsin et al., 2001). In 1992, WSSV 
was first discovered in northern Taiwan, causing the white-spot disease outbreak 
(Chou et al., 1995) and it quickly spread to other shrimp-farming areas in Southeast 
Asia, such as Thailand and Indonesia (Flegel, 1997). WSSV was initially limited to 
Asia until the virus was reported in Texas and South Carolina in late 1995 (Lu et al., 
1997). Within a few years it spread to Central and South America and by 1999 this 
viral disease has also been detected in Europe and Australia (van Hulten et al., 2000a). 
As such, WSSV has become a global viral disease and major threat in shrimp 
aquaculture. 
WSSV has been found across different shrimp species and has an even 
broader host range in crustaceans (Hameed et al., 2003). WSSV was initially detected 
in the marine shrimp Penaeus (Fenneropenaeus) chinensis. Within several years the 
new viral agent has spread to all shrimp species including Penaeus monodon and 
Penaeus (Litopenaeus) vannamei, the two most cultured species. Besides, WSSV can 
also attack crabs, copepods and other arthropods such as lobsters (Panulirus homarus 
and Panulirus ornatus) and crayfish (Procambarus clarkii). Up to date, at least 18 
cultured or wild penaeid shrimp species have been found to be WSSV-positive by 
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PCR. More than 80 different crustacean species have been reported as host or carriers 
of WSSV in both culture facilities and the wild as well as in experimental infection 
experiments (Chen et al., 2000a; Syed Musthaq et al., 2006; Yoganandhan and 
Hameed, 2007; Yoganandhan, Narayanan, and Sahul Hameed, 2003). Many of these 
crustaceans can support WSSV replication under experimental conditions, while 
some species collected from the wild have only been found to be WSSV positive by 
PCR, which indicates that these species may act as carriers or reservoirs of WSSV to 
marine shrimp (Hsu et al., 1999; Kiatpathomchai et al., 2005; Maeda et al., 2000; 
Vaseeharan, Jayakumar, and Ramasamy, 2003; Withyachumnarnkul, 1999; 
Wongteerasupaya et al., 2003). 
1.2 Pathology and tissue tropism of WSSV 
Penaeid shrimp species infected with WSSV display obvious white spots or 
patches of 0.5–3.0 mm in diameter embedded in the exoskeleton. The exact 
mechanism of white spot formation has not been identified yet, but it possibly results 
from the accumulation of calcium salts within the cuticle due to the dysfunction of the 
integument after WSSV infection. In cultured shrimp, WSSV infection also causes 
additional clinical signs, including slow swimming, preening and response to stimulus, 
a loose cuticle and reduced feed consumption. Diseased shrimp are lethargic and 
reach 100% mortality within 3-4 days after the onset of the disease. Histopathology 
has revealed that WSSV-infected shrimp tissues are of ectodermal and mesodermal 
origin. (Hammer, Stuck, and Overstreet, 1998; Lu et al., 1997b; Wongprasert et al., 
2003; Wu et al., 2002). 
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Several similarities including virus morphology and proteome (composition) 
have been found among several WSSV isolates, and preliminary studies indicated that 
there is little difference in virulence between WSSV isolates, although direct 
comparisons were not made (Lan, Lu, and Xu, 2002). Further studies however 
compared the virulence of six geographic isolates of WSSV (WSSV-Cn, WSSV-In, 
WSSV-Th, WSSV-Texas, WSSV-South Carolina and WSSV from infected crayfish 
maintained at the USA National Zoo) in two different penaeid species (P. vannamei 
postlarvae, and F. duorarum, juveniles) which were orally inoculated. All six WSSV 
isolates caused 100% mortality after challenge in P. vannamei postlarvae with 
WSSV-Tx being the isolate which caused mortality most rapidly, while the crayfish 
isolate caused mortality the slowest. In contrast, mortality caused by WSSV-Tx in 
juveniles of F. duorarum reached 60%, while mortality with the crayfish isolate 
reached only 35% (Wang Q., 1999). Furthermore, a comparative study was conducted 
between the isolate containing the largest genome identified at present, WSSV-Th-
96-II (considered as the common ancestor of all WSSV isolates described to date), 
and WSSV-Th, with the smallest genome identified so far. The median lethal time 
(LT50) upon exposure of P. monodon, via intramuscular injection, to the WSSV-Th-
96-II inocula was significantly longer (14 days) than the LT50 observed after exposure 
to WSSV-Th (3.5 days). When both isolates were mixed in equal amounts and 
serially passaged in shrimp, WSSV-Th outcompeted WSSV-Th-96-II within four 
passages. In fact, only the genotype of WSSV-Th was detected in the DNA isolated 
after passage 5, which suggested the presence of a single isolate, WSSV-Th, and not 
isolate WSSV-Th-96-II or a recombinant form of WSSV genotype consisting of a 
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mosaic of WSSV-Th and WSSV-Th-96-II. These data suggest a higher virulence of 
WSSV-Th compared to WSSV-Th-96-II. Thus, a smaller genome may give an 
increase in viral fitness by faster replication (H, 2005). 
The success of any viral infection is its successful replication which is mainly 
determined by the interaction between the viral attachment proteins (VAP) and the 
host’s specific cellular receptors (Triantafilou, Takada, and Triantafilou, 2001) 
(several proteins contain a cell attachment signature). As previously mentioned, 
WSSV can infect a wide range of crustacean and non-crustacean hosts, which suggest 
that WSSV has a VAP that can bind to common targets on different cells in a variety 
of hosts (Liang Y., 2005) . Until today, it has been widely accepted that after infection, 
WSSV can replicate in all the vital organs of penaeid shrimp (Lo C.F., 1997; Syed 
Musthaq et al., 2006). However, it is recognized that tissue or cell tropism results 
from highly specific interactions between a virus and the cell type it infects, which 
implies that viruses are not capable to infect all types of cells indiscriminately. More 
recently, it was reported that WSSV infects mainly cells in tissues of ectodermal 
(cuticular epidermis, fore- and hindgut, gills, and nervous tissue) and mesodermal 
(lymphoid organ, antennal gland, connective tissue, and hematopoietic tissue) origins 
(Wongteerasupaya C., 1995b), while tissues of endodermal origin (hepatopancreatic 
tubule epithelium and midgut epithelium) are resistant to WSSV infection. However, 
orally WSSV-infected shrimp showed that once the virus has crossed the basal 
membrane of the digestive tract, virions are present, in the nucleus of circulating 
hemocytes at different stages of morphogenesis, suggesting that viral replication must 
be occurring in this cell type. Thus, hemocytes carrying virions are dispersed in the 
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hemocoel through hemolymph circulation and are rapidly distributed to different 
tissues (Di Leonardo et al., 2005). Since shrimp, as all arthropods, possess an open 
circulatory system it is not surprising that the hemocytes are also found in other 
tissues, which may explain why WSSV has been detected in several tissues. 
Furthermore, a significant decline in the number of circulating hemocytes (van de 
Braak C.B.T., 2002), as well as an increase in the number of apoptotic hemocytes 
(Sahul-Hameed A.S., 2006) has been reported after WSSV infection. This may be 
caused by infection of the hemocytes or by an apoptotic event in the WSSV infected 
hematopoetic tissue (Wongprasert et al., 2003). Among the different types of 
hemocytes found in shrimp, semigranular cells (SGC), which comprise ∼58% of the 
hemocytes, were more vulnerable to be infected by WSSV than granular cells 
(prevalence of less than 22%) (Kanchanaphum P., 1998). An interesting observation 
was that granular cells from non-infected crayfish exhibited melanisation when 
incubated in L-15 medium, while no melanisation was observed in granular cells 
from infected organisms. This either may suggests that the WSSV is capable to 
inhibit the prophenoloxidase system upstream of phenoloxidase (which may play a 
role against WSSV), or that this virus simply consumes the native substrate for the 
enzyme so that no activity is shown (Di Leonardo et al., 2005). Finally, it seems 
feasible that WSSV infects specific cell types in the hematopoietic tissue, of which 
semigranular cells seem more prone to be infected. 
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1.3 WSSV genome and classification 
The WSSV genome consists of a double-stranded circular DNA of about 300 
kb, which has been completely sequenced on three WSSV isolates (Thailand 293 kbp, 
China mainland 305 kbp, Taiwan 307 kbp). Subsequent analysis revealed that the 
WSSV genome includes about 180 open reading frames (ORFs). So far, around 30% 
of these ORFs have been functionally annotated, including structural proteins and a 
variety of enzymes involved in DNA replication and repair, gene transcription, and 
protein modification. The remaining potential gene products are known only as 
hypothetical proteins (Lo C.F., 1997; Syed Musthaq et al., 2006). 
Since its appearance in 1992, the causative viral agent of White Spot 
Syndrome has been named in several ways. Originally the etiological agent was 
described as rod-shaped enveloped bacilliform pathogenic virus, named RV-PJ (rod-
shaped nuclear virus of P. japonicus) (Inouye K., 1994). Later, based on its particle 
shape, it was renamed as Penaeid rod-shaped DNA virus (PRDV) and the 
correspondly disease was named penaeid acute viremia (PAV) (Inouye K., 1996). 
During the 1995 outbreak suffered in Thailand the disease was informally called 
systemic ectodermal and mesodermal baculovirus (SEMBV) because of its 
morphology, size, and histopathological profile (Wongteerasupaya C., 1995b). The 
hypodermal and hematopoietic necrosis virus (HHNBV) was considered as the 
etiological agent of the prawn explosive epidemic disease (SEED) suffered in China 
from 1993 to 1994 (Cai S., 1995). The virus from the People's Republic of China has 
also been called Chinese baculovirus (CBV). The virus has also been taxonomically 
affiliated as: China virus disease, red disease (Alapide-Tendencia E.V., 1997), white 
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spot disease, and white spot baculovirus. However, presently the virus is referred to 
as white spot syndrome virus (WSSV).  
Virus classification places the viruses in a series of classes or taxonomic 
categories with a hierarchical structure, the ranks being the species, genus, family and 
order (van Regenmortel et al., 2000). The species is the basic taxonomic group in 
biological systematics and it has been proposed that the species concept can be 
extended to viruses because they are true biological entities, not simply chemicals. 
Like all other biological entities, viruses show intrinsic genetic variability, which 
leads them to become adapted through the scrupulous scrutiny of natural selection, 
and guarantees their survival (Van Regenmortel, Maniloff, and Calisher, 1991).  
At first, it was proposed that based on its morphology, size, site of assembly, 
cellular pathology (widespread degenerated cells with severely hypertrophied nuclei 
and marginated chromatin in tissues of ectodermal and mesodermal origin), and 
nucleic acid content, WSSV (SEMBV) should be assigned to the subfamily 
Nudibaculovirinae, family Baculoviridae, where it would be formally named 
PmNOBII, as the second non-occluded baculovirus (NOB) reported for a shrimp 
species (P. monodon) (Wongteerasupaya C., 1995a). During the same year similar 
conclusions were reached for a WSBV isolate that was considered a different virus at 
that time. It was proposed that this virus should also be classified as a member of the 
subfamily Nudibaculovirinae, of Baculoviridae and named it PmNOBIII (a third non-
occluded baculovirus reported for P. monodon) (Wang H.C., 2003). However, changes 
in nomenclature in the sixth report of the International Committee on Taxonomy of 
Viruses (ICTV) removed the genus NOB and the subfamily Nudibaculovirinae 
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(Murphy F.A., 1995), classifying WSSV into the unassigned invertebrate viruses 
group, mainly due to the lack of molecular information (van Hulten et al., 2000b). 
Only two genera, Nucleopolyhedrovirus and Granulovirus, were included in the 
family Baculoviridae, and, due to its characteristics, WSSV was unlikely to belong to 
either (Lo C., 1996). 
Although WSSV is morphologically similar to insect baculovirus, the two 
viruses are not detectably related at the amino acid level. While WSSV has repeated 
regions that are similar to those of some baculoviruses, most ORFs encode proteins 
with poor sequence homology to any known proteins. This suggests that WSSV 
represents a novel class of viruses or that there exists a significant evolutionary 
distance between marine and terrestrial viruses. Thus, on the basis of phylogenetic 
analysis, WSSV has been classified in a novel virus genus (Escobedo-Bonilla et al., 
2008). 
Additionally, different approaches showed uncertainty about the taxonomic 
status of WSSV. First, a phylogenetic study based on ribonucleotide reductase (rr1 
and rr2) genes revealed a lack of significant gene homology between WSSV and 
baculoviruses, indicating a low degree of relatedness among these viruses (van Hulten 
et al., 2000a). Second, DNA sequence analysis of two major structural proteins (VP26 
and VP28) showed no homology to baculovirus structural proteins (van Hulten et al., 
2000b). Third, transcriptional analysis of the WSSV rr genes showed that their 
regulation involves unique promoters, which are not found in baculoviruses (Tsai et 
al., 2000). Finally, a phylogenetic analysis comparing the WSSV protein kinase (PK) 
gene with PKs from several viruses and eukaryotes separated WSSV from 
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baculoviruses (Van Hulten and Vlak, 2001). As a result, WSSV was proposed as 
either a representative of a new genus (Whispovirus) within the Baculoviridae, or a 
representative of a new virus family, Whispoviridae (van Hulten et al., 2000a; van 
Hulten et al., 2000b). Since 2002 the ICTV included WSSV as the type species of the 
the genus Whispovirus, family Nimaviridae (Mayo, 2002). The family name reflects 
the most notable physical feature of the virus: a tail-like polar projection (“nima” is 
Latin for “thread”). Thus, the white spot syndrome virus is the sole species of a new 
monotypic family called Nimaviridae (genus Whispovirus) (Marks et al., 2004). 
1.4 Morphology and Structural proteins of WSSV  
White spot syndrome virus is a bacilliform, non-occluded, enveloped DNA 
virus with a tail-like appendage at one end. A virion is a complex assembly of 
macromolecules exquisitely suited for the protection and delivery of viral genomes. 
WSSV virions consist of an envelope surrounding a rod-shaped nucleocapsid. The 
viral envelope is a lipidic, trilaminar membranous structure of 6–7 nm thickness with 
two electron-transparent layers divided by an electron-opaque layer. Located inside 
the envelope, the nucleocapsid typically measures 65±70 nm in diameter and 
300±350 nm in length. It is a stacked ring structure composed of globular protein 
subunits of 10 nm in diameter. These protein subunits are arranged in 14–15 vertical 
striations and are located every 22 nm along the long axis, giving the capsid a cross-
hatched appearance. The nucleocapsid extends in length once it is released from the 
envelop (Durand et al., 1997; Escobedo-Bonilla et al., 2008; Lu et al., 1997a; Nadala, 
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Tapay, and Loh, 1998; Park et al., 1998; Rodriguez et al., 2003; van Hulten et al., 
2000b). 
The structural proteins of virions are of particular importance, since these 
proteins are the first molecules to interact with the host, and therefore play critical 
roles in cell targeting as well as in the triggering of host defences. More than 39 
structural proteins have been located in the WSSV virion (Tsai et al., 2004). Of these, 
21 have been found in the envelope (van Hulten, Goldbach, and Vlak, 2000), 10 in 
the nucleocapsid and five in the tegument (a putative structure located between the 
envelope and the nucleocapsid) (Leu et al., 2005; Tsai et al., 2006; Xie, Xu, and Yang, 
2006).  
Among the structural proteins, VP28 is the most abundant protein of the 
WSSV envelope. It has been widely studied and was selected as the major target on 
WSSV (Tang et al., 2007; van Hulten et al., 2001b). In vivo neutralization assays 
using antibodies against VP28 showed a significant delay in the onset of shrimp 
mortality (Yoganandhan et al., 2004), indicating that VP28 might play an important 
role in virus penetration (Yi et al., 2004). Similarly, RNA interference with either 
double stranded RNA or small interfering RNA targeting VP28 reduced the mortality 
in WSSV infected shrimp (Sarathi et al., 2008a; Sarathi et al., 2008b). A 25-kDa 
membrane protein from shrimp hemocytes, with high homology to the small GTP-
binding protein Rab7, was found to interact with recombinant VP28 and WSSV 
virions (Sritunyalucksana et al., 2006). This finding suggests a function for VP28 in 
cell attachment. 
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Furthermore, the envelope proteins VP31, VP110 and VP281, the tegument 
protein VP36A and the nucleocapsid proteins VP664 and VP136A were suggested to 
contribute to virus entry with a cell attachment motif (Tsai et al., 2006). 
Neutralization assays with anti-sera for VP68, VP281, VP466 and VP24 have also 
shown to protect shrimp from WSSV infection, indicating that these proteins are 
required for virus penetration (Ha et al., 2008; Huang et al., 2005; Li, Xie, and Yang, 
2005). Recently, a few studies have revealed that the viral tegument protein VP26 
functions as a linker between the envelope and nucleocapsid of virions by binding 
with VP51 (Chang et al., 2008; Wan, Xu, and Yang, 2008). Future research will be 
required to identify the location and uncover the function of additional structural 
proteins of WSSV. 
1.5 Non-structural proteins in WSSV 
Most of the non-structural proteins identified in WSSV so far play important 
roles as regulatory proteins. A number of non-structural genes from WSSV which 
show homology to known sequences in the databases have been identified and 
characterized. These include genes encoding the large and small subunits of 
ribonucleotide reductases (Lin et al., 2002), a novel chimeric cellular type thymidine–
thymidylate kinase (Tzeng et al., 2002), a serine/threonine type protein kinase (Van 
Hulten and Vlak, 2001), an endonuclease (Witteveldt, Van Hulten, and Vlak, 2001), 
and a DNA polymerase (Chen et al., 2002).  
Furthermore, three latency-associated genes (LAG) were identified from 
specific-pathogen-free shrimp by microarray (Khadijah et al., 2003). Despite high 
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prevalence in natural populations, persistent viral life strategy has not received much 
attention. Persistence has been defined as the state in which a virus maintains its 
capacity for either continued or episodic reproduction in an individual host, 
subsequent to an initial period of productive infection and occurrence of an antiviral 
host response. This definition also includes the condition known as latency in which 
virus reproduction can be partially or completely suppressed for prolonged periods, 
but the capacity for reactivation is maintained (Villarreal, Defilippis, and Gottlieb, 
2000). Among these WSSV LAGs, ORF89 was found to be a transcription repressor 
(Hossain, Khadijah, and Kwang, 2004) and WSSV427 was shown to interact with a 
shrimp phosphatase (Lu and Kwang, 2004).  
A microarray based approach has also been employed in a WSSV study to 
find three immediate early (IE) genes (Liu et al., 2005). They may be important 
proteins to determine host range and also function as regulatory trans-acting factors 
during infection. As shown in a recent paper, IE 1 protein displays transactivation, 
dimerization, and DNA-binding activity (Liu et al., 2008). Interestingly, the promoter 
to drive IE1 transcription, namedIE1 promoter, has a high activity in many cell types, 
including insect and mammalian cells. Therefore, IE1 promoter has been used as a 
shuttle promoter in vaccine delivery and gene transduction. Specifically, it has been 
employed for the efficient production of influenza vaccines (He, Madhan, and Kwang, 
2009). 
Other proteins with a putative function include a collagen-like protein 
flagellin (Li, Chen, and Yang, 2004), a chitinase, a pupal cuticle-like protein, a cell 
surface flocculin, a kunitz-like proteinase inhibitor, a class 1 cytokine receptor 
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(Huang et al., 2005), as well as a sno-like peptide and a chimeric anti-apoptotic 
protein (Escobedo-Bonilla et al., 2008; Wang et al., 2004). Most recently, advances 
on WSSV non-structural proteins indicated the identification of a DNA mimic protein 
ICP11 (Wang et al., 2008a) and an anti-WSSV shrimp C-type lectin LvCTL1  (Zhao 
et al., 2009).  
Through different molecular (WSSV-infected EST database and WSSV DNA 
microarray) and proteomic (2D electrophoresis) approaches, it was found that the 
WSSV gene ICP11 (also identified as VP9) is the most highly expressed viral gene at 
both transcriptional and translational levels (it was 3.5-fold more highly expressed 
than the major envelope protein gene VP28). Its encoded protein, ICP11, is a non-
structural protein localized in both cytoplasmic and nuclear compartments (Wang H.C., 
2007; Wang et al., 2008a), and contains a fold and a negative charge comparable with 
those recognized in dsDNA, suggesting that it may function by mimicking the DNA 
shape and chemical character (Wang et al., 2008a). Furthermore, it was found that 
ICP11 binds directly to the DNA binding site of nucleosome-forming histones (H3 
and H2A.x), thus interfering, thus, with critical functions of DNA damage repair, and 
nucleosome assembly, which has been reported as a mechanism to manipulate 
cellular chromatin in order to ensure viral genome survival and propagation (Cowsill 
et al., 2000). 
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1.6 Vaccine strategies for the control of WSSV 
infection 
The scientific literature concerning the immune system of crustaceans is 
abundant. It is widely accepted that crustaceans, as most invertebrates, lack a true 
adaptive immune response system and that their defense against pathogens relies on 
various innate immune mechanisms, including both cellular and humoral responses 
(Tincu and Taylor, 2004). Thus, the development of a vaccine against WSSV, or 
other shrimp pathogens, has been severely impeded by the absence of memory-type 
immunity and by the lack of a comprehensive knowledge about the etiology of the 
disease. However, the presence of a quasi-immune response against WSSV was 
detected in the shrimp P. japonicus (Venegas et al., 2000). In this study, organisms 
that survived a WSSV outbreak were experimentally re-challenged four months after 
the devastating event. A relative survival of 94% was observed, which, according to 
the authors, suggested that the resistance of organisms previously infected with 
WSSV was due to the enhancement of an immune-like system (quasi-immune 
response) (Venegas et al., 2000). Further studies implied that the resistance developed 
by surviving organisms against WSSV was due to an unknown WSSV neutralizing 
factor component of the shrimp plasma (Wu et al., 2002), suggesting that some sort of 
adaptive immune response could exist in shrimp. However, the nature of this 
neutralizing factor remains to be investigated. Now it is widely accepted that the 
transfer of DNA or RNA to somatic cells may contribute to influence the immune 
system of the organism, and such new kinds of vaccines have already been employed 
to prevent a wide range of infectious and malignant diseases. This technology has 
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also been applied to the control of WSSV infection. Nucleic acid-based vaccines 
seem to be a very promising and valuable short-term approach against WSSV. 
Recent studies have reported that the injection of dsRNA into shrimp may 
induce a general antiviral response regardless of its sequence. Interestingly, there is 
evidence of significant reductions in cumulative mortalities in the shrimp P. vannamei 
experimentally infected with Taura Syndrome Virus (TSV) or WSSV, and previously 
injected with dsRNA transcribed from the gene for the duck (A. platyrhynchos) Ig  
heavy chain (Robalino et al., 2004). As this sequence has no similarity to any known 
shrimp gene or to the reported genomes of WSSV or TSV it suggested that the 
observed antiviral response was not mediated by a RNAi-gene silencing mechanism, 
but instead it may represent a more general antiviral mechanism active against two 
unrelated viruses. Furthermore, WSSV-infected shrimp injected with dsRNA for 
VP19 showed a much higher pathogen-specific protection, when compared with those 
injected with randomly generated dsRNAs, suggesting that shrimp can use pathogen-
specific RNAi systems to generate highly targeted protection against viral diseases 
(Robalino et al., 2005). Similar results have been observed by intramuscular injection 
of dsRNAs corresponding to VP28 and VP281 in P. chinensis, indicating that 
dsRNA-mediated protection is a common feature across shrimp species (Kim et al., 
2007). however, the injection of short interfering RNAs (siRNAs) failed to induce a 
similar response, which implies a minimum size requirement for extracellular dsRNA 
to engage antiviral mechanisms and gene silencing (Robalino et al., 2005).  
Other reports have suggested that the oral administration of bacterially 
expressed VP28 dsRNA could become a therapeutic agent against WSSV as dsRNA 
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treated shrimp challenged with WSSV showed higher survival rates (68%) compared 
to organisms vaccinated with feeds coated with inactivated bacteria containing empty 
vector (Sarathi et al., 2008b). It is suggested that VP28dsRNA may act by silencing 
the expression of the WSV002 gene as a decline of its transcripts was detected 
(Sarathi et al., 2008a).  
In the same way, when dsRNA of Rab7 (a WSSV-VP28 binding protein) was 
injected into shrimp before challenging with WSSV or Yellow Head Virus (YHV) 
viral replication was significantly inhibited. Rab7 gene silencing was observed after 
48 h after the injection of dsRNA, which also reduced the VP28 mRNA levels and, 
consequently, virus protein expression. Thus Rab7 may function in the endosomal 
trafficking pathway, and its silencing might prevent viral trafficking necessary for 
replication (Ongvarrasopone et al., 2008).  
Finally, it has been reported that siRNA could suppress the gene expression 
and replication of WSSV. Shrimp injected with VP15 or VP28 siRNAs, before a 
WSSV challenge, showed a significantly lower mortality rate, similiar to that of those 
shrimp injected with green fluorescent protein (GFP) siRNA, which implies that 
siRNAs may induce a sequence-independent antiviral response when injected into 
shrimp (Westenberg et al., 2005). On the contrary, experimentally WSSV-infected 
shrimp P. japonicus injected with a specific 21 bp short interfering RNA (VP28-
siRNA) targeting the VP28 gene of WSSV showed lower mortalities than control 
organisms. When treated with vp28-siRNA, the expression of VP28 gene and the 
replication of viral DNA were significantly delayed or inhibited, indicating a 
sequence-specific response (Xu, Han, and Zhang, 2007). 
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Recent studies have reported that protection was conferred (for up to 50 days) 
to experimentally WSSV-infected shrimp P. monodon injected with recombinant 
DNA plasmids encoding the envelope proteins VP28 or VP281, while the injection of 
DNA expressing the WSSV nucleocapside proteins VP15 and VP35 did not elicite a 
protective response. Besides, it was found that shrimp vaccinated with recombinant 
DNA showed a longer protection effect (up to 50 d p. v.), whereas those organisms 
vaccinated with the envelope protein VP28 were protected at 14 but not 25 d p. v. 
(Rout et al., 2007). Furthermore, it has been demonstrated that those organisms 
vaccinated with recombinant DNA encoding VP28 showed enhanced levels of 
prophenoloxidase and superoxide dismutase, which suggests that these 
immunological parameters may confer resistance to shrimp against WSSV (Rajesh 
Kumar et al., 2008). 
More recently, several studies have begun to use recombinant WSSV 
envelope proteins to induce resistance to WSSV in shrimp. A significantly higher 
resistance (lower mortality rates) to WSSV has been reported in P. japonicus 
vaccinated by injection with rVP26 once. Also, when organisms were vaccinated 
intramuscularly twice with rVP28 at a 20 day interval, mortality was reduced to 4% 
(Namikoshi A., 2004). The protective response was effective at 10 days post-
vaccination (d p.v.), but not 30 d p.v., which suggests that mechanisms involved in 
this response may be different from those observed when organisms survive after 
exposure to infective WSSV. Similarly, lower cumulative mortalities were observed 
in P. monodon after oral or intramuscular vaccination with rVP28, rVP19 (Witteveldt 
et al., 2004; Witteveldt J., 2004), and rVP292 (Vaseeharan et al., 2006). Interestingly, 
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utilizing the WSSV IE1 promoter, VP28 can be localized to the baculovirus envelop 
with its structural and antigenic conformity intact and this recombinant baculovirus 
can be used as an effective oral vaccine against WSSV (Syed Musthaq et al., 2009). 
Some of the results obtained in the above mentioned studies suggest the 
existence of an adaptive secondary immune response in invertebrates, homologous to 
that observed in vertebrates (Witteveldt et al., 2004; Wu et al., 2002). This point has 
been discussed in a number of publications, and it has been emphazised that the 
information of such phenomenological observations is still insufficient to support the 
case of adaptive immunity in invertebrates. Thus, such observations cannot be used in 
isolation and should not be used solely as the basis for radical claims contrary to well-
established knowledge of innate immunity. They can, of course, be used to propose 
hypotheses that must be scientifically supported and exhaustively tested. Besides, it 
must be established if immune mechanisms found in invertebrates are homologous to 
those in vertebrates, as functional similarity in the immune system does not prove 
homology (Hauton C., 2007).  
 Finally, oral vaccination of shrimp against WSSV seems as a very promising 
control strategy. However, adequate laboratory and field studies must be done prior to 
the release of a potential WSSV vaccine, which would require several years of 
research. Thus, it is not expected that such a vaccine will be available in the next few 
years. 
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1.7 Virus-related apoptosis in host cells 
Apoptosis has been shown to play a critical role in vertebrate defense against 
viral pathogens (Hasnain et al., 2003; O'Brien, 1998). In mammals, apoptosis can 
play two contradictory roles in the pathogenicity of viral infection: suppression or 
enhancement, depending on the situation. In general, virus-induced apoptosis 
suppresses pathogenicity by taking a principal role in limiting inflammatory reactions 
at the site of infection and by inducing specific immunity. In contrast, apoptosis 
enhances HIV-1 pathogenicity by inducing massive cell death in indispensable organs, 
signaling the onset of disease (Cossarizza, 2008; Velilla et al., 2005). Although 
replication of most viruses is suppressed by apoptosis of infected cells, certain viruses 
can grow significantly in cells undergoing apoptosis (Liu et al., 2006; Liu, Chen, and 
Kwang, 2005). In insects (which lack adaptive immunity), apoptosis has been 
reported to be an extremely powerful host defence mechanism which limits viral 
replication, infectivity, and spread through the premature lysis of infected cells 
(Clarke and Clem, 2003; Clem, 2001). The occurrence of apoptosis upon viral 
infection has also been observed in crustaceans (Rijiravanich, Browdy, and 
Withyachumnarnkul, 2008; Wang et al., 2008b; Wongprasert et al., 2003). For 
example, in WSSV infected shrimp, apoptotic cells have been detected in several 
viral target tissues of shrimp and the level of apoptosis seems to increase as white 
spot disease progresses towards shrimp death. In the viral accommodation theory it 
has been hypothesized that virus triggered apoptosis may be a major cause of 
mortality and that reduced rates of cell death may allow for attenuation of viral 
pathogenicity in shrimp. Despite these findings, there is still no clear conclusion as to 
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the relative contribution of apoptosis to viral pathogenicity and/or host defensive 
responses in shrimp.          
1.8 Ubiquitination in virus infection 
Ubiquitin-mediated proteolysis plays an important role in a variety of basic 
pathways and processes during cell life and death. In the ubiquitin-dependent 
proteolytic pathway, ubiquitin is linked to substrates through a well-organized 
process involving the sequential action of a ubiquitin-activating enzyme (E1), a 
ubiquitin-conjugating enzyme (E2), and a ubiquitin ligase (E3) (Fu et al., 1998; 
Glickman and Ciechanover, 2002). Recently, a novel ubiquitination factor (E4) was 
shown to be involved in polyubiquitin chain assembly (Koegl et al., 1999). 
Polyubiquitinated proteins are then targeted to the 26S proteasome for degradation 
(Ciechanover, 2001; Ciechanover, Orian, and Schwartz, 2000; Glickman and 
Ciechanover, 2002; Schwartz and Ciechanover, 1999). Deubiquitination enzymes 
mediate the removal and processing of ubiquitin (Kim et al., 2003; Lu et al., 2009). 
Aberrations in this pathway are implicated in the pathogenesis of many 
diseases, certain malignancies, and neurodegeneration. Similarly, viruses have 
evolved the ability to utilize the host protease machinery to direct cellular protein 
degradation to increase their survival and replication (Boutell, Sadis, and Everett, 
2002; Liu, 2004; Thomas, Pim, and Banks, 1999). Ubiquitination plays a key role in 
viral infection and facilitates activities required for various aspects of the virus 
replication cycle from entry (Galinier et al., 2002), through replication (Everett et al., 
1999; Parkinson and Everett, 2001), enhanced cell survival (Thomas, Pim, and Banks, 
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1999; Winberg et al., 2000), to viral release (Rost et al., 2006; Segura-Morales et al., 
2005; Yasuda et al., 2002). For example, human papillomavirus employs a 
mechanism for proteolytic removal of p53 that enables continuous replication and 
propagation of the virus under conditions of DNA damage that would otherwise result 
in p53-induced apoptosis (Scheffner et al., 1993; Shackelford and Pagano, 2005). To 
avoid recognition by immune surveillance for latent or chronic infection, human 
herpes virus down-modulates major histocompatibility complex-I chains via two 
transmembrane protein-modulators of immune recognition, MIR1 and MIR2, in a 
plant homeodomain motif-dependent manner (Coscoy and Ganem, 2003; Coscoy, 
Sanchez, and Ganem, 2001). In the process of human immunodeficiency virus (HIV) 
budding, the PATP motif of the HIV Gag protein mediates direct binding with the 
UEV (ubiquitin E2 variant ) domain in the N-terminus of Tsg101 (tumor 
susceptibility gene 101), and two E3 ligases have been identified as regulators of HIV 
budding (Klinger and Schubert, 2005; Li and Wild, 2005). In addition, ubiquitination 
of APOBEC3G by an HIV-1 Vif-Cullin5-Elongin B-Elongin C complex is essential 
for Vif (virion infectivity factor) function (Kobayashi et al., 2005). 
1.9 RING-containing proteins in WSSV 
A previous study (Freemont, 2000) has revealed that the RING finger domains 
of E3 ubiquitin ligases are involved in specific ubiquination events. It is now 
recognized that the RING finger domain is present in the largest known class of E3 
ubiquitin ligases (Borden, 2000; Yang and Yu, 2003). It has functions involved in 
cell-cycle control, oncogenesis and apoptosis as well as in the regulation of virus 
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replication in the host (Yang and Yu, 2003; Yang and Li, 2000). In general, RING 
finger proteins possess the motif Cys-X2-Cys-X(9–39)-Cys-X(1–3)-His-X(2–3)-Cys-
X2-Cys-X(4–48)-Cys-X2-Cys, where X can be any amino acid (Borden, 2000). They 
are characterized by a highly conserved three dimensional structure that binds two 
zinc ions in a cross-brace structure for conformational stability. The RING finger 
family has two subclasses: RING-HC and RING-H2 (where His replaces Cys4), 
which are important motifs with established functions (Pickart, 2001).  
Four WSSV proteins, WSSV199, WSSV222, WSSV249, and WSSV403, 
have been predicted to encode the RING-H2 motif (Yang et al., 2001) (Fig. 1). 
Among them, WSSV249, acting as an E3 ligase, sequesters the shrimp E2 ubiquitin-
conjugating enzyme PvUbc for viral pathogenesis (Wang et al., 2005). Furthermore, 
WSSV249 exhibited a low degree of specificity to human E2s, such as UbcH7, 
UbcH8, UbcH12, and UbcH13 as well as to two shrimp ubiquitin-conjugating 
enzymes PvUbcH1 and PvUbcH5b. WSSV infection upregulates transcripts of 
PvUbcH1 and PvUbcH5b, and also induces a higher protein expression of PvUbc, 
PvUbcH1, and PvUbcH5b, leading to increased ubiquitination. Therefore, the low 
specificity of E3 ubiquitin ligase WSSV249 from WSSV disturbs the balance of the 
shrimp ubiquitin-26S proteasome pathway, leading to viral pathogenesis. 
1.10 Research outline and objectives 
Although there is some information about virion structure, epidemiology, 
pathogenicity, and genome sequence of WSSV, little is known about the molecular 
mechanisms underlying the WSSV life cycle and mode of infection. In addition, the 
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study of WSSV is difficult because there is no established shrimp cell line and whole 
shrimp systems have not been well studied. Moreover, the uniqueness of the WSSV 
makes it hard to compare to other virus infection models. For unique viruses with a 
large genome like WSSV, it is thus important to reveal its infection mechanism, 
which might throw a light on new regulatory pathways in virus-host interaction. As 
suggested by previous findings on WSSV RING proteins (Wang et al., 2005), they 
might play key roles in WSSV pathogenicity and infection machinery. Studies 
focusing on the potential function of RING proteins in viral regulation will certainly 
pave the way for an increased understanding of WSSV and other viral infection 
mechanisms. Therefore, to fully determine the function of RING proteins in WSSV, 
emphasis in this study is placed on the WSSV222 and WSSV403 proteins and the 
following research objectives were established: 
1. Identification of viral E3 ubiquitin ligase activity of these RING containing 
proteins in WSSV. 
2. Determination of the transcription profile of the viral E3 ligases during WSSV 
infection. 
3. Identification and characterization of host/shrimp interaction partners of these viral 
E3 ligases. 
4. Functional studies on these viral E3 ligases and their interaction partners during 
WSSV infection in shrimp. 





Figure 1  
 
 
Fig.1. WSSV222, 249 and 403 contain RING-H2 domains. (A) Schematic 
representation of WSSV222 and 403 proteins by SMART program. WSSV222 RING 
domain is from 308aa to 358 aa , while WSSV403 from 329 aa to 370 aa. Pink bars 
indicated segments of low compositional complexity on WSSV222. Green bars 
indicated coiled coil regions on WSSV 403. (B) Alignment of the RING portion from 





































Chapter 2  
WSSV222 encodes a viral E3 ligase and 
mediates degradation of a host tumor 














White spot syndrome virus (WSSV) is a virulent shrimp pathogen responsible 
for high mortality in cultured shrimp, raising major concerns in the aquaculture 
industry. Disease outbreaks can reach a cumulative mortality of up to 100% within 3 
to 7 days of infection (Lightner, 1996). Its circular dsDNA genome consists of 300 
kbp that contains approximately 185 open reading frames (van Hulten et al., 2001a; 
Yang et al., 2001), and is one of the largest viral genomes. Database searches reveal 
that more than 95% of these ORFs do not have any counterparts in other species and 
WSSV has thus been placed in a new virus family, the Nimaviridiae, genus 
Whispovirus (van Hulten et al., 2001a). So far, only a few non-structural genes from 
WSSV which show homology to known sequences in the databases have been 
identified and characterized, such as a ribonucleotide reductase (Tsai et al., 2000) and 
a DNA polymerase (Chen et al., 2002). At the molecular level there is little 
understanding of how WSSV establishes latent infections or of the genes responsible 
for the transition between latent and lytic infection, which eventually leads to 
mortality. 
Ubiquitin-dependent proteolysis serves a central regulatory function in many 
biological processes such as cell cycle regulation, signal transduction and 
transcriptional regulation (Borden, 2000; Liu, 2004; Yang and Yu, 2003). Importantly, 
ubiquitin-mediated degradation of cellular tumor suppressors is essential for the 
regulation in cell division and apoptosis, and many apoptosis regulatory proteins have 
been identified as target substrates for ubiquitination. It is therefore not surprising that 
many viruses possess their own E3 ligases for ubiquitination and degradation of host 
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tumor suppressors to achieve a quiescent cellular environment for virus replication 
(Banks, Pim, and Thomas, 2003; Vaux and Silke, 2005), such as ICP0 from Herpes 
simplex virus type 1 (Boutell and Everett, 2003; Everett, 1999) and E6AP from 
human Papillomavirus (Thomas, Pim, and Banks, 1999). In Baculovirus the inhibitor 
of apoptosis (IAP) proteins function as E3 ligases and the number of identified 
cellular targets of this class of proteins, which include caspases, is increasing (Vaux 
and Silke, 2005). 
In this Chapter, efforts were made to fully characterize viral protein 
WSSV222. As one of RING containing proteins from WSSV, WSSV222 functions as 
a RING-dependant E3 ligase. Yeast two-hybrid and pull-down analyses revealed that 
WSSV222 interacts with a shrimp tumor-suppressor-like (TSL) protein. The 
extensive identity shared by the human OVCA1 (ovarian cancer 1) tumor suppressor 
(Chen and Behringer, 2005; Schultz et al., 1996) and TSL suggested a role for TSL in 
apoptosis regulation. Here we show that TSL has a role in regulating the cell cycle 
and that WSSV222 inhibits apoptosis. Biochemical analyses show that WSSV222 can 
interact with and mediate the ubiquitination and degradation of the TSL, and that this 








2.2 Materials and Methods 
2.2.1 RACE PCR, wild type and mutants cloning. 
Full-length WSSV222 and 222RING sequences ranging in size from 637-
1494 bp were amplified from viral DNA that had been extracted previously (Khadijah 
et al., 2003) with primer pairs 222f (5′-ATGTTCACTCACTTGACC-3′) and 222r (5′-
TTAGATTAAAGTAAAACAGTACAT-3′), and 222RINGf (5′-
CCTACTACTAGCCAACAC-3′) and 222RINGr (5′-GCGCATCTGTATTTGTCT-3′) 
respectively. WSSV222 mutations C311S, H336Y, 307DEL347 were created using a 
Quick Change site-directed mutagenesis kit (Stratagene) according to manufacturer’s 
instructions. 
Forward (5′-GGCATACGATGGTGTGTCCCTCGGG-3′) and reverse 
primers (5′-GGGCTGGTCATAGTATTCACGGGAAAGGAC-3′) were designed to 
determine the transcription start site of shrimp TSL using a RLM-RACE kit (Ambion) 
according to the manufacturer’s instructions. RACE products were ligated to pGEM-
T Easy (Promega) and sequenced. Together with 3′ end sequence information from 
the original library insert sequencing, forward (5′-
ATGAATATGGAGGAAGATACGCA-3′) and reverse (5′-
ATCTTTATTACTTCCTTGTTTAGAGCT-3′) primers for the full length TSL were 
designed to amplify the full length TSL fragment. 
DNA isolation, purification, and transformation techniques used are described 
elsewhere (Sambrook, Russell, and Sambrook, 2001). PCR reactions were performed 
in 50 µL volumes containing templates, primers 800 µM dNTPs, 1.5 mM MgCl2, 1× 
Taq DNA polymerase reaction buffer and 2 U of Taq DNA polymerase (Qiagen). 
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Reactions were commenced with an initial denaturation at 94 ºC for 7 min, followed 
by 30 cycles of 94 ºC for 20 s, 55 ºC for 30 s and 72 ºC for 2 min. Reactions were 
completed with a final extension at 72 ºC for 7 min. PCR products mixed with 6x 
loading buffer (50 % w/v glycerol, 0.25 % w/v bromophenol blue) were 
electrophoresed on a 1 % low melting temperature agarose gel (Biorad) in TAE 
buffer (89 mM Tris, pH 8.0, 110 mM boric acid, 2 mM EDTA) at a constant voltage 
of 120 V cm–1.  
2.2.2 Construction of shrimp cDNA library.  
The shrimp cDNA library was construction by Genomax, Singapore. Total 
RNAs were extracted from normal WSSV-free shrimps (Penaeus vannamei) (33). 
First-strand cDNAs were reverse transcribed from 0.3 ug of total shrimp RNAs, using 
Powerscript reverse transcriptase with SMART Oligo II and CDS primers (Clontech). 
Nonnormalized double-stranded cDNAs were amplified from the newly synthesized 
firststrand cDNAs using SMART PCR primer (Clontech). Normalization of 
firststrand cDNAs and SMART-amplified cDNAs were performed according to the 
protocols described by Zhulidov et al. (63). The amplified normalized cDNAs were 
purified using the QIAquick PCR purification kit (QIAGEN), ligated into SrfI-
modified pGADT7 vector (Clontech), and subsequently transformed into Escherichia 
coli (XL1-Blue) cells by electroporation. The shrimp cDNA library was screened for 
inserts by PCR with primers T7 (5 -TAATACGACTCACTATAGGGC- 3 ) and 
AD3 (5 -AGATGGTGCACGATGCACAG- 3 ) (Clontech) on 40 randomly 
selected colonies. The size of shrimp gene fragments that colonies carry range from 
300 bp to 3kb. The library was then arrayed in 30 plates to obtain 1:500,000 
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independent colonies, which were eluted by LB ampicillin medium and stored at 
70°C.  
2.2.3 Yeast two-hybrid assays. 
Two-hybrid assays were performed using the Matchmaker GAL4 kit 
(Clontech). Growth conditions, media, and transformation protocols were as 
described by the manufacturer. Full-length WSSV222 gene was amplified with 
primer pairs 222bamf (5′-agcggattccATGTTCACTCACTTGACC-3′) and 222salr (5′-
atcgtcgacTTAGATTAAAGTAAAACAGTACAT-3′) and inserted in to pGBKT7 
with BamHI and SalI sites, The bait construct pGBKT7-222 and the shrimp cDNA 
library (Genomax) in pGADT7 were used to cotransform yeast strain AH109. The 
transformation was carried out according to manufacturer’s instructions (BD 
Clontech). Transformants were selected for growth on –His/–Leu/–Trp dropout 
medium until 5days posttransformation. The selected colonies were further 
transferred to –Ade/–His/–Leu/–Trp plates containing 250 µl X-α-gal (2 mg/ml in 
DMF, Genomax) per 15 cm plate. Blue colonies were selected and cultured in –Ade/–
His/–Leu/–Trp broth and lysed with glass beads (Sigma) for plasmid isolation in lysis 
buffer (2% Triton X-100, 1% SDS, 100 mM NaCl, 10 mM Tris-HCl, pH 8.0, 1 mM 
EDTA). Clarified with plasmid purification column (Qiagen), isolated plasmids were 
amplified in E. coli DH5α on LB agar plates containing either Amplicilin (100ug/ml) 
or Kanamycin (50ug/ml) and the target insertions verified by sequencing. Target and 
bait plasmids were then cotransformed into AH109 to reconfirm the interactions on   
–Ade/–His/–Leu/–Trp plates containing 250 µl X-α-gal (2 mg/ml in DMF, 
Genomax) . 
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2.2.4 Expression, purification of proteins and antibody preparation. 
Wild type 222RING  and its mutants were ligated to pQE30 (Qiagen) using 
BamHI and SalI sites with primer sets 222RINGfb (5′-
ggatccCCTACTACTAGCCAACAC-3′) and 222RINGrsa (5′-
gtcgacGCGCATCTGTATTTGTCT-3′) for construction of expression plasmids. 
Transformed E. coli M15 (pREP4) cells were cultured in LB with ampicillin (200 
µg/ml) at 16ºC to O.D. 0.6 and induced with 1 mM isopropyl-1-thio-β-D-
galactopyranoside (IPTG) for more than 4 hours. Full-length WSSV222 was 
expressed using the Bac-to-Bac system (Invitrogen) according to manufacturer’s 
instruction. Bacteria or SF9 cells were harvested by centrifugation, resuspended in 
lysis buffer with Ni-NTA beads and lysed by sonication. The expressed proteins were 
then bound to Ni-NTA beads (New England Biolabs) and washed with buffers under 
native conditions. The purified protein-conjugated beads were then denatured at 
100ºC for 10 min in Laemmli sample buffer prior to denaturing SDS-PAGE on a 12% 
gel at constant voltage of 100V. Gels were stained with Coomassie Brilliant Blue R-
250 and silver nitrate (Blum et al., 1987) and scanned with a Bio-Rad GS-800 
densitometer.  
For western blotting, proteins were electroblotted onto a PVDF membrane 
followed by blocking in 5% BSA. Blots were probed with a 1:2000 dilution of mouse 
anti-His6 (New England Biolabs) followed by a 1:2000 dilution of horse radish 
peroxidase-conjugated rabbit anti-mouse IgG (DAKO Cytomation) prior to 
development of the diaminobenzene substrate.  
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Plasmids pGEX4T-TSL and pGEX4T were transformed into E. coli DH5α. 
Cultures in LB with ampicillin were grown to mid-log phase at 37ºC before being 
induced with 1 mM IPTG for 5 h at 25ºC. Bacterial pellets were resuspended in PBS, 
lysed by sonication and clarified by centrifugation at 3000 ×g for 15 min. GST-TSL 
and GST proteins were bound to glutathione sepharose 4B beads (Amersham) and 
eluted from beads in PBS containing 50 mM glutathione. The purified proteins were 
verified on 12% SDS polyacrylamide gels and by immunoblotting with an anti-GST 
antibody (Pierce) followed by a 1:2000 dilution of horse radish peroxidase-
conjugated rabbit anti-mouse IgG (DAKO Cytomation) prior to development of the 
diaminobenzene substrate.  
Mice were boosted three times with the same quantities (100ug) of antigen 
emulsion with oil adjuvant (Seppic, France) for TSL or WSSV222 every other day for 
14 days. Ten days after the final booster injection, the animals were exsanguinated 
and sera collected. 
2.2.5 Pull-down assays. 
 Cell lysates from WSSV222 and mutant expression constructs were incubated 
with purified GST-TSL or GST protein (negative control) at 4ºC for 4 h. The 
mixtures were clarified by centrifugation at 1500 ×g for 10 min, supernatants 
precleared using fresh GST beads, and then washed in ice-cold wash buffer (100 mM 
Tris-HCl [pH 8.0], 150 mM NaCl, 5% glycerol, 0.1% Nonidet P-40, 5 mM β-
mercaptoethanol) five times at 4ºC. The beads were then denatured in Laemmli 
sample buffer prior to SDS-PAGE and immunoblotting with anti-His6 and anti-GST 
antibodies for one hour respectively followed by a 1:2000 dilution of horse radish 
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peroxidase-conjugated rabbit anti-mouse IgG (DAKO Cytomation) prior to 
development of the diaminobenzene substrate. 
2.2.6 Primary cell culture, immunofluorescence and confocal microscopy. 
The development of primary cell cultures of lymphoid organ tissue from P. 
vannamei followed the description of Wang et al (Wang and Yang, 2000). Excised 
lymphoid organs were excised from adult Penaeus vannamei and separated into small 
fragments using sterilized forceps, then incubated at 28°C in 2× L15 (Sigma) 
complete medium containing 20% FBS. The original medium was removed with the 
unattached tissue after 12 h. The remaining cells were inoculated with WSSV in 
serum-free 2× L15 medium for 1 h and were then changed into fresh complete 
medium.. 
 The cells were fixed with 100% ethanol for 15 mins at 24 h postinoculation 
and then incubated with anti-TSL or anti-222 serum (1:50 dilution in PBS) and FITC-
conjugated anti-guinea-pig IgG or anti-mouse IgG (1:50 dilution in PBS, DAKO) 
sequentially at 37°C. Finally, the cells were observed under a fluorescence 
microscope. 
A2780 cells (Fox Chase cancer center) were grown in RPMI medium 
supplemented with 10% FBS and 0.33 IV/mal porcine insulin at 37ºC. BHK (Baby 
Hamester Kidney) cells were grown in DMEM medium supplemented with 10% FBS 
at 37 ºC. The cells were transfected with the pWSSV222-EGFP or pTSL-EGFP, 
pcDNA-TSL or vector (negative control) using Lipofectamine and Plus reagents 
(Invitrogen), as described by the manufacturer. Clones that stably expressed TSL 
were obtained after selection in G418 (GIBCO) by standard methods and maintained 
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in RPMI supplemented with 10% FBS and 0.5 mg/ml G418. For degradation assays, 
the A2780 cells were treated with 30 µM MG132 (Boston Biochem) overnight to 
allow accumulation of TSL. 1x106 cells were suspended into final volume of 200ul. 
20ug total protein was loaded to SDS PAGE from each sample. For microscopy, the 
cells were fixed at different stages by 4% PFA. The primary antibody used was anti-
TSL guineapig serum. The secondary antibody was Rhodamine-conjugated rabbit 
anti-guineapig IgG (Chemicon). Nuclei were stained with DAPI (Invitrogen) and 
fluorescence observed under a confocal inverted laser microscope (Zeiss) with 
excitation recorded at 568 nm (red), 488 nm (green) or 420 nm (blue). Channels were 
recorded independently to avoid cross talk between the channels.  
2.2.7 Ubiquitination assays in vitro and in vivo.  
E1 and E2 enzymes used in this experiment were purchased from Boston 
Biochem. In vitro ubiquitin conjugation assays were performed in a buffer containing 
50 mM Tris-HCl (pH 7.5), 5 mM MgCl2 and 2 mM ATP. The concentration of 
protein and enzymes used were as follows: 50 nM E1, 250 nM E2, 5 µg ubiquitin 
(Sigma), approximately 200 ng of WSSV222, 222RING, C310S, H336Y, ∆307/347 
and 200 ng of TSL. For in vivo ubiquitination assays, total protein was extracted from 
TSL-expressing A2780 cells previously tranfected with plasmids containing EGFP-
222 or EGFP, or from shrimp primary cells in the presence of protease inhibitor 
(Roche). Proteins were collected by sequential incubation of cell extracts with the 
appropriate antibody and Protein A beads (Clontech). After a 4 h incubation at 30ºC 
the reactions were quenched with Laemmli sample buffer and subjected to 
electrophoresis on a 10% SDS-polyacrylamide gel. Proteins were transferred to a 
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nitrocellulose membrane for immunoblotting and then probed sequentially for one 
hour each using anti-ubiquitin monoclonal P4D1 (1:1000; Santa Cruz Biotechnology) 
and horseradish peroxidase conjugated rabbit anti-mouse immunoglobulin G (IgG; 
1:1000) for in vitro assays, and anti-TSL (1:1000) and rabbit anti-guinea-pig IgG 
(1:1000) for in vivo assays. Bound antibody was detected using enhanced 
chemiluminescence reagent (Pierce) and exposure on film.  
2.2.8 DNA Fragmentation Assays.  
BHK cells were transfected by electroporation with a Gene Pulser (Bio-Rad) 
using the preset BHK program. Low-molecular-weight DNA was isolated from 
transfected cells with Apoptotic DNA Ladder Kit (Roche) according to the 
manufacturer’s instructions. Equal amounts of DNA were resolved on a 2 % agarose 
gel containing ethidium bromide. 
2.2.9 FACS Analysis.  
Cells were harvested, washed with PBS and fixed with 75% ethanol at room 
temperature for 30 min, followed by treatment with 10 µg/ml RNase at 37ºC for 30 
min. Nuclei were stained with 50 µg/ml propidium iodide (Clontech) for 30 min. The 
cells were filtered through a 40 µm nylon mesh and then analyzed by flow cytometry 
(BD Immunocytometry systems). Data for 10,000 events were gathered by CellQuest 











2.3.1 WSSV222 is a RING-H2 E3 ligase. 
An initial characterization of the putative protein encoded by WSSV ORF222 
revealed the presence of a RING finger domain (Notredame, Higgins, and Heringa, 
2000) similar to those from mammals and viruses (Fig. 2A). The presence of a 
C3H2C3-type RING finger suggested that WSSV222 belongs to the RING-H2 
subgroup and could be involved in protein-protein interactions. 
To focus on the RING domain function of WSSV222, we constructed and 
expressed a partial WSSV222 protein, termed 222RING, which contains the RING-
finger-domain (P212-R498) (Fig. 2B). E3 ligases are known to specifically stimulate 
E2-conjugating enzymes based on their specific interaction with the E3 ligase RING-
finger domain of E3 (Joazeiro and Weissman, 2000; Joazeiro et al., 1999). To 
determine if WSSV222 possessed ubiquitination activity in vitro and which, if any, 
E2 enzyme stimulated this activity, we incubated purified 222RING with a range of 
different E2 enzymes in the presence of all the other components in an in vitro 
ubiquitination assay. E3 ligase activity of 222RING was strongly stimulated only by 
UbcH6 while the other E2 enzymes tested showed no stimulation in spite of their 
normal conjugating activity (Fig. 2C). Among these the activation of E2, UbcH1, H2, 
H3, H5a, H5b, H5c, H6, H9 and H10 has been reported by our laboratory previously 
(Wang et al., 2005), while UbcH7, H8, H12 and H13 were incorporated into the study 
but did not stimulate 222RING activity. Based on this observation, we introduced 
full-length WSSV222 to the assay. Both full-length WSSV222 and 222RING 
autoubiquitinated in the presence of the other components, including UbcH6 (Fig. 
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2D). This result indicated that WSSV222 is indeed an E3 ligase and that it 
specifically recognizes UbcH6, resulting in autoubiquitination. The 222RING 
fragment, which covers a complete RING-H2 domain, is sufficient and independent 
to support such E3 ligase activity. 
To further investigate the RING domain function of WSSV222, we prepared a 
number of mutant derivatives of 222RING (Fig. 2B). C311S and H336Y are 
WSSV222 RING finger mutants with an altered C3H2C3 RING-finger structure, and 
are thus unable to bind monovalent zinc ions, which are required for E3 ligase 
activity (Borden, 2000). Mutant 307∆347 lacks most of the RING-finger domain 
thereby abolishing its ubiquitination function. Expressed proteins were verified by 
immunoblotting using anti-His6 (Fig. 2E). Wild type 222RING and mutant proteins 
were then included in ubiquitination assays and the reactions analyzed by 
immunoblotting using monoclonal anti-ubiquitin antibody to detect E3 ligase 
activities in vitro. Only the wild type 222RING protein showed a ladder-like smear at 
high-molecular weight protein sizes, which can be attributed by polyubiquitin chains 
in the presence of E1, UbcH6 and ubiquitin (Fig. 2E). In contrast, none of the mutated 
RING finger proteins showed polyubiquitination activity with the same input amount 
(Fig. 2E). These results indicate that the intact RING domain in WSSV222 is both 









Fig. 2. WSSV222 is a RING-containing E3 ligase. (A) Sequence alignment of the 
N-terminal portion WSSV222 with related proteins. The WSSV222 RING domain is 
of the C3H2C3 type (CX2CX9-39CXHX2HX2CX4-48CX2C), similar to that of 
Arabidopsis (ARA-T) and ORF MSV251 (Melanoplus sanguinipes entomopoxvirus). 
Black highlights consensus residues for RING structure among the three species. (B) 
Schematic representation of WSSV222 protein and mutant constructs. (C) In vitro 
conjugation assay using anti-ubiquitin antibody P4D1. A panel of different E2 
enzymes was screened for activity in the presence of 222RING. The negative control 
reaction was performed in the absence of E2.  (D) Both full length WSSV222 and 
RING domain of WSSV222 have poly-ubiquitination activity under a specific E2 
enzyme UbcH6. The negative control reaction was performed in the absence of E1 or 
E2. (E) Effects of mutations in WSSV222 on the in vitro conjugation reaction. 
Purified mutant and wild type 222RING proteins were subjected to an in vitro 
ubiquitination assay using E1, UbcH6 and ubiquitin. Same amount of E3 ligase was 
input detected by anti-His6 antibody 
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2.3.2 TSL, a shrimp orthologue for OVCA1, is a WSSV222 target. 
To elucidate the function of the RING domain in WSSV222 and the 
significance of its E3 ligase function for WSSV infection, we investigated the 
protein-protein interactions between the virus and its host using a yeast two-hybrid 
system. From these assays a putative WSSV222 partner was identified. The amino 
acid sequence of this construct has high similarity to the human tumor suppressor 
OVCA1 (ovary cancer gene 1). OVCA1 is expressed ubiquitously in human tissues 
and mammalian cell lines to varying degrees (Jensen and Helin, 2004), and its 
expression inhibits tumor growth in vivo and in vitro (Bruening et al., 1999). The 
sequence obtained by yeast two-hybrid from the shrimp cDNA library is shorter than 
OVCA1 and  apparently lacked the N-terminal region. The complete sequence with a 
Kozak consensus start codon was determined from shrimp cDNA by 5′ RACE and 
was named shrimp TSL (tumor suppressor-like). The full length shrimp TSL 
(AAU13908) was predicted to be 1272 bp and the encoded protein shares 60% and 
59% amino acid sequence identity with human and mouse OVCA1, respectively (Fig. 
3A). There is no conserved motif or known functional domain in either shrimp TSL 
or mammalian OVCA1. To further understand the function of shrimp TSL, we 
established a TSL-expressing cell line in the A2780 human ovarian cancer cell line. 
Expression of TSL in these cells was confirmed from several clones by 
immunoblotting with an anti-TSL antibody although expression levels varied 
somewhat (Fig. 3C). FACS assays with either clone A or B also indicated that TSL is 
expressed in A2780 cells and it suppressed cell growth at the G1 phase: a 15-17% 
increase of the number of cells in G1 phase was observed in these cells compared 
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with a vector transformed control (Fig. 3B). This property of TSL in regulating the 
cell cycle closely resembles the activity of human OVCA1 (Jensen and Helin, 2004). 
TSL was localized throughout the cell from TSL clone A but mainly in the cytoplasm 
(Fig. 3D), which corresponds to the localization pattern of human OVCA1 (Bruening 
et al., 1999). Taken together, these data indicate that shrimp TSL is an orthologue of 













































Fig. 3. Shrimp tumor suppressor-like (TSL) protein is functionally similar to 
human OVCA1. (A) Amino acid sequence alignment of the shrimp tumor 
suppressor-like (TSL) protein and related proteins. TSL is 60% and 58% homologous 
to the human and mouse OVCA1 proteins, respectively. (B) Flow cytometry analysis 
of TSL-expressing A2780 cells. Cell cycle distributions were determined at 24 h post-
seeding by FACS. DNA profiles represent cell number (events) along the ordinate 
and DNA content along the abscissa. The percentage of cells in the G1 and G2 phase 
of the cell cycle is listed. A2780 represents the original cells; vector is the vector 
control; TSLA, B are the TSL-expressing cell lines from colony A and B. (C) 
Immunoblot showing exogenous TSL expression in TSL-expressing A2780 cells 
detected in different clones with anti-TSL antibody. (D) TSL localization in A2780 
cells with TSL clone A. TSL-expressing A2780 cells were fixed at 24 h post-seeding 





2.3.3 WSSV222 interacts with and ubiquitinates TSL in vitro. 
To further confirm the interaction between TSL and WSSV222, GST pull-
down assays were performed between shrimp TSL and WSSV222 (Fig. 4A). TSL-
GST but not GST interacted with full-length WSSV222 from a total cell lysate thus 
forming soluble complexes that could be isolated by glutathione sepharose. His6-
tagged WSSV222 was detected by anti-His6 antibody in the TSL-GST sample, which 
was clearly absent in the GST control (Fig. 4A). Meanwhile, both TSL-GST and GST 
could be detected by anti-GST antibody, showing bands corresponding to their 
respective molecular weights. Experiments performed with 222RING and its mutants 
revealed that all of the proteins specifically interacted with GST-TSL, but not with 
GST, indicating that an intact RING domain is not essential for protein-binding and 
that 222RING includes a TSL interaction domain other than the RING domain. 
Immunoblot data confirmed the strong protein-protein interaction between shrimp 
TSL and WSSV222 as observed from yeast two-hybrid assays, whereby yeast 
colonies cotransformed with either shirmp TSL and full-length WSSV222 or shrimp 
TSL and 222RING can grow under high stringency conditions.  
E3 ligases interact with several different components, such as E2 enzymes and 
substrates for ubiquitination (Joazeiro and Weissman, 2000). To determine the role 
that TSL plays for WSSV222, we included purified GST-TSL in our 
polyubiquitination reaction. In the presence of all components including WSSV222 as 
an E3 ligase, GST-TSL was polyubiquitinated, as indicated by a high-molecular 
weight smear (Fig. 4B). This strong signal was detected by anti-GST, but was absent 
in the GST control. Polyubiquitination was also eliminated when WSSV222 was not 
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included in the assay. In these experiments, GST was used as a tag to identify the 
poly-ubiquitin signal but not ubiquitin, indicating that this assay is specific for 
polyubiquitin signals generated from ubiquitinated substrate rather than from 
WSSV222 E3 ligase. These data indicate that TSL is a substrate for the WSSV222 E3 
ligase for polyubiquitination in vitro. And similar result was also observed in the 
same test with 222RING but not in any of the WSSV222 RING mutants. This result 
confirmed that substrate ubiquitination depended on E3 ligase activity and that the E3 





















Fig. 4. WSSV222 interacts with and ubiquitinates shrimp tumor-suppressor–like 
protein in vitro. (A) His6-WSSV222 pull-down assay was performed using soluble 
extracts of E. coli or SF9 expressed WSSV222 mixed with GST-TSL. Soluble protein 
complexes were bound to GST beads and washed under high stringency condition 
before SDS-PAGE and immunoblot detection of His6-WSSV222 and 222RING. 
Immunoblots were performed with anti-His6 or anti-GST. (B) In vitro 
polyubiquitination assay performed using WSSV222, 222RING, RING mutants with 
TSL in the presence of E1, E2 and ubiquitin. SDS-PAGE resolved complexes were 









2.3.4 TSL is ubiquitinated for degradation by WSSV222 in vivo.  
To test whether TSL is also ubiquitinated in vivo, we performed ubiquitination 
assays using A2780 cells. Thus, TSL-expressing A2780 cells (TSL clone A) were 
transfected with pWSSV222-EGFP or pEGFP. Total protein extracted at 24 h post-
transfection was incubated with anti-ubiquitin antibody and Protein A beads. TSL 
protein was then immunoprecipitated and analyzed by immunoblotting with anti-TSL 
primary antibody. TSL precipitated from the pWSSV222-EGFP transfected cell was 
polyubiquitinated, giving a high molecule weight smear, while the sample from the 
pEGFP control did not (Fig. 5C). We also performed such tests with 222RING and its 
mutants. As expected from our in vitro results, 222RING expression but not that of 
the RING mutants resulted in the ubiquitination of TSL (Fig. 5C), confirming that 
ubiquitination of TSL depends on the RING domain of the WSSV222 E3 ligase. To 
further clarify the fate of TSL ubiquitinated by WSSV222, we transfected TSL-
expressing A2780 cells with pWSSV222-EGFP or pEGFP and subjected the cells to 
an indirect immunofluorescence assay with anti-TSL antibody. We observed by 
confocal microscopy that cells transfected with EGFP-222 failed to yield a TSL-
specific signal (Fig. 5A). Degradation of TSL was also detected in the presence of 
222RING but not with the RING mutants, further verifying that degradation of TSL is 
mediated by E3 ligase-dependent ubiquitination. 
We next sought to determine if TSL was being degraded via the 26S 
proteasome pathway, as would be expected for ubiquitin-mediated proteolysis. To 
accomplish this we treated one set of transfected cells with MG132, a 26S proteasome 
inhibitor, and subjected the transfected cells to immunoblotting with anti-TSL 
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antibody. We observed a decrease in the amount of TSL expressed in cells 
cotransfected with pWSSV222-EGFP and recovery by MG132 treatment, indicating 
that WSSV222 can degrade shrimp TSL via the 26S proteasome pathway. In the 
absence of WSSV222 expression, no obvious change in TSL expression level was 
detected in the TSL-expressing cell line treated with MG132 compared with original 
TSL cells (Fig. 5B). Therefore, the TSL recovered following MG132 treatment is 




















Fig. 5. WSSV222 ubiquitinates and mediates degradation on shrimp TSL in vivo. 
(A) Localization of WSSV222 and TSL in A2780 cells (TSL clone A). TSL-
expressing A2780 cells were transfected with pWSSV222-EGFP, p222RING-EGFP 
and its mutants, or pEGFP. At 24 h post-transfection, cells were fixed and stained 
with anti-TSL antibody and rhodamine anti-guinea pig. Note the absence of TSL 
expression in cells containing WSSV222-EGFP and 222RING-EGFP. (B) 
Degradation of TSL by WSSV222 detected by immunoblotting with extracts from 
TSL-expressing A2780 cells harvested at 24 h post-transfection. TSL expression is 
recovered by MG132 treatment. (C) In vivo polyubiquitination of TSL. Cell lysates 
were prepared from TSL-expressing A2780 cells 24 h after transfection with 
pWSSV222-EGFP, p222RING-EGFP and its mutants, or pEGFP, and subjected to 
immunoprecipitation with anti-ubiquitin antibody from mouse. Proteins were 
analyzed by immunoblotting with anti-TSL antibody from guinea pig. IP, 






2.3.5 TSL is subjected to ubiquitination and degradation in WSSV-infected 
shrimp cells.  
To investigate the interactions between WSSV222 and shrimp TSL during 
WSSV infection, we performed immunofluorescence assays with shrimp primary 
cells. WSSV222 expression was detected with anti-WSSV222 among primary cells at 
24 h postinoculation but not in uninoculated cells based on anti-WSSV222 
fluorescence signals. Weaker fluorescence from TSL occurred in infected cells 
compared to uninfected ones suggesting degradation of TSL after WSSV infection 
(Fig. 6B). Coimmunoprecipitations using infected and uninfected cell lysates 
incubated with 5 µM MG132 showed that TSL from the infected lysate was 
polyubiquitinated, while that in the uninfected lysate was not (Fig. 6A). WSSV222 
was detected in the lysate precipitated by anti-TSL antibody (Fig. 6A), verifying the 
interaction between WSSV222 and TSL in shrimp tissue culture. Moreover, the 
recovered WSSV222 was polyubiquitinated, clearly showing that it functions as an 
E3 ligase in shrimp cells. These results confirm the role of WSSV222 as a viral E3 












Fig. 6. TSL is degraded and ubiquitinated in WSSV-infected shrimp cells. (A) 
Co-immunoprecipitation and immunoblotting with total protein lysate from shrimp 
primary cells at 24 h postinoculation in the presence 5 µM MG132. IP, 
immunoprecipitation. Uninoc. Uninoculated cells; WSSV, WSSV-inoculated cells. (B) 
Immunofluorescence assays with shrimp primary cells. Cells were fixed at 24 h post-
inoculation and stained with anti-TSL and anti-WSSV222 antibodies, respectively. 
Uninoculated cells are controls. Uninoc. Uninoculated cells; WSSV, WSSV-
inoculated cells; DIC, differential interference contrast; IFA, immunofluorescence 











2.3.6 WSSV222 rescues apoptosis induced by transient expression of TSL in 
BHK cells.  
The nature of WSSV222-mediated TSL degradation in vivo was investigated 
by transiently expressing both TSL and WSSV222 in BHK cells. Membrane blebbing 
and DNA fragmentation were observed in TSL-expressing cells while cells 
transfected with the EGFP parent vector still appeared healthy as revealed by 
confocal microscopy (Fig. 7A). Additionally, DNA exacted from TSL-expressing 
cells at 24 and 48 h exhibited clear fragmentation (Fig. 7B), indicating cell apoptosis 
induced by TSL transient expression. This DNA fragmentation was rescued by 
cotransfection with pWSSV222-EGFP, but not with the pEGFP control (Fig. 7C), 
indicating that WSSV222 can inhibit the apoptosis induced by TSL overexpression. 
Apoptotic blebbing was not observed in TSL-expressing A2780 cells, suggesting that 

















Fig. 7. WSSV222 antagonizes TSL-induced apoptosis in BHK cells. (A) Apoptotic 
blebbing of TSL-expressing BHK cells. Cells were transfected with pTSL-EGFP or 
pEGFP and fixed at 24 h post-transfection. (B) DNA fragmentation analysis. DNA 
was extracted from transfected BHK cells at 24 or 48 h post-transfection and 
subjected to agarose gel electrophoresis. DNA fragmentation is evidenced by 




















This is one of the first reports that sheds light on the molecular mechanism of 
WSSV infection, and reveals a link between infection and host protein degradation. 
During virus infection, the targeting of cellular proteins for proteasomal degradation 
via ubiquitination is an important aspect of virus survival and replication (Banks, Pim, 
and Thomas, 2003; Coscoy and Ganem, 2003; Lomonte, Sullivan, and Everett, 2001; 
Parkinson, Lees-Miller, and Everett, 1999). Among them, cellular tumor suppressors 
are the main targets of many E3 ligases for the purpose of cell survival and 
transformation because they can induce apoptosis in infected cells to restrict infection 
(Banks, Pim, and Thomas, 2003; Fang et al., 2000; Thomas, Pim, and Banks, 1999; 
Vaux and Silke, 2005). Here we have identified an E3 ubiquitin ligase, WSSV222, 
from WSSV and also its cellular substrate, a shrimp tumor suppressor-like protein. 
Our data suggest that the proteolytic pathway in which WSSV222 and TSL are 
involved may serve as an anti-apoptotic mechanism in host cells to ensure WSSV 
replication.  
The number of potential E3 ligases present in sequence databases has been 
increasing rapidly in recent years (Fang et al., 2003). In this study, we have shown 
that WSSV222 is a genuine E3 ubiquitin protein ligase from WSSV that can 
specifically interact with an E2 conjugating enzyme and mediate transfer of ubiquitin 
to a specific substrate protein. The specificity displayed by WSSV222 may be 
attributed to its recognition of the extra C-terminal extension or tail of the core 
domain of UbcH6, which is a unique characteristic for Class II E2 enzymes (Kus et 
al., 2004). Three WSSV222 mutants with mutations or deletions in the RING-H2 
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domain fail to catalyze ubiquitination, thus confirming that the E3 ligase activity of 
WSSV222 is dependent on the RING structure.  Moreover, mutations in the RING 
structure do not effect interaction between WSSV222 and TSL, confirming that this 
domain is not involved in substrate binding. That the 222RING fragment of 
WSSV222 autoubiquitinates and binds TSL clearly indicates that this region contains 
the E3 ligase function of WSSV222. More work is required to identify the exact 
binding site for substrates, which will bring a better understanding to this viral E3 
ligase. 
To date, no stable and transfectable shrimp cell line has been established. 
Moreover, efficient expression of certain genes in shrimp primary cells has not been 
achieved by groups working on WSSV. Therefore, here we have instead used human 
A2780 cells to investigate aspects of the TSL-WSSV222 interaction. According to 
previous study, A2780 cells, human ovarian cancer cell, is one of the only cell lines 
for successful stable expression of OVCA1, suggesting that overexpression of 
OVCA1 either blocks growth or is toxic to the cells (Bruening et al., 1999). From 
data presented here it is clear that OVCA1 and TSL share functional similarity in 
human and shrimp cells, and that TSL is able to function effectively in a mammalian 
background. Most importantly, to clarify the roles of WSSV222 and TSL during 
WSSV infection, we further verified these results in shrimp primary cells (Itami and 
Maeda, 1999; Wang and Yang, 2000) by confocal microscopy and 
immunoprecipitation, proving that WSSV222 is a viral E3 ligase and that TSL is 
ubiquitinated and degraded after WSSV infection. 
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The identified ubiquitination target of WSSV222, termed TSL, shares 60% 
homology with human OVCA1, which is a tumor suppressor associated with ovarian 
carcinoma and which regulates cell proliferation and tumorigenesis (Bruening et al., 
1999; Chen and Behringer, 2004; Chen and Behringer, 2005; Jensen and Helin, 2004; 
Schultz et al., 1996). OVCA1, when stably expressed in the ovarian carcinoma cell 
line used here, induces a 10–20% increase in the proportion of cells in the G1 phase. 
Consistent with these results, stable TSL expression induced a 16% increase in cells 
present in the G1 phase, indicating shrimp TSL has similar function with OVCA1 in 
cell cycle regulation. TSL expression in A2780 cells still permitted cell growth, 
though the rate of growth was somewhat reduced exhibiting a prolonged G1 phase, 
quite similar to the situation in OVCA1-expressing A2780 cells (Bruening et al., 
1999). The precise role of OVCA1 in human tumor suppression remains unclear, 
though further work in our laboratory on TSL and WSSV222 function may well 
contribute to a better understanding of its role in human ovarian cancer in addition to 
furthering our knowledge of WSSV infection. 
A degree of biological relevance of the TSL-WSSV222 interaction was 
established to be showing that WSSV222 functions as an anti-apoptotic protein. TSL 
can induce apoptosis in BHK cells, confirming its tumor suppressor function in 
mammalian cells. BHK cells are widely used for apoptosis studies (Shih et al., 2004; 
Sun, Khoo, and Tan, 2005; Udawatte and Ripps, 2005), and retain many molecular 
components of the apoptosis cascade (Arden and Betenbaugh, 2004). Moreover, this 
tumor suppressor effect was antagonized by WSSV222, which highlights the role of 
WSSV222 as a viral anti-apoptotic protein. These findings have implications not only 
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for WSSV but also for the potential role of human OVCA1. Preliminary yeast two 
hybrid data indicate that TSL also interacts with other proteins similar to mammalian 
proapoptotic and antiapototic regulators, such as prohibitin (Fusaro et al., 2003; Wang 
et al., 1999a), a potential tumor suppressor associated with breast cancer and 
cathepsin B (Podgorski and Sloane, 2003; Sloane et al., 2005), a cysteine protease 
with elevated expression in different cancer tissues and cells. All these data are 
indicative of TSL’s role as a regulator of apoptosis and tumor suppression. WSSV 
infection results in apoptosis in shrimp cells (Wang et al., 2004), and the current work 
suggests that TSL may play an essential role in this process. Meanwhile, WSSV222 
here is implyed to be the strategy WSSV employs to inhibit such a tumor suppressor 
in host.  
Ubiquitination on tumor suppressors is important in different cellular 
regulation (Yang, Li, and Weissman, 2004; Yang and Yu, 2003). Besides 
polyubiquitination, monoubiquitination is also involved in modification of tumor 
supressor in vivo, such as p53 (Asher and Shaul, 2005; Brooks, Li, and Gu, 2004; Li 
et al., 2003). In our studies, without WSSV222 or 222 RING, cellular TSL protein 
was precipitated by anti-ubiquitin antibody, although no polyubiquitination signals 
was detected (Fig 5D and 6A), implying a part of TSL may be monoubiquitinated in 
vivo and regulated by other ubiquitination machinary rather than WSSV222. 
In our study we have characterized WSSV222 function as an E3 ubiquitin 
ligase and identified a tumor suppressor-like protein, TSL, from shrimp as a substrate 
for WSSV222. Upon interacting with WSSV222, shrimp TSL protein is ubiquitinated 
and degraded via the 26S proteasome. These reactions serve as an anti-apoptotic 
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process to favor host cell survival and WSSV replication. This finding elucidates one 
of the first described WSSV infection mechanisms, and thus improves our 





































Chapter 3  
Viral ubiquitin ligase WSSV222 is required 






















White spot syndrome virus (WSSV) is a virulent shrimp pathogen responsible 
for high mortality in cultured shrimp, raising major concerns in the aquaculture 
industry. Disease outbreaks can reach a cumulative mortality of up to 100% within 3 
to 7 days of infection (Escobedo-Bonilla et al., 2008). Histopathological and 
molecular features of cell apoptosis were detected in shrimp tissue at the early stage 
of WSSV infection, such as nuclear hypertrophy and DNA fragmentation (Sahtout, 
Hassan, and Shariff, 2001; Wang et al., 1999b). The apoptosis level increases during 
the entire infection process and eventually contributes to virus pathogenicity. 
Apoptosis plays a critical role in vertebrate defense against viral pathogens 
(McLean et al., 2008; O'Brien, 1998). Upon virus infection, host-induced apoptosis in 
individual infected cells limits viral replication, infectivity, and spread. Similarly, in 
the invertebrates, apoptosis is also an extremely powerful response to virus infection, 
which has been mainly characterized in insects with baculovirus infection (Clem, 
2005). Wongprasert et al. (2003) have reported the different levels of apoptosis in 
Penaeus monodon infected with WSSV. Several studies have been carried out to 
investigate the changes in the level of apoptosis-related gene expression in WSSV-
infected shrimp, such as shrimp caspase and tumor proteins (Bangrak et al., 2004; 
Leu et al., 2008; Wang et al., 2008b). Some viral proteins function as anti-apoptosis 
proteins against host defense system for successful viral replication in the host. In 
WSSV, a few viral proteins were found to inhibit apoptosis in different mechanisms 
(Wang et al., 2004). WSSV449 was identified as a caspase inhibitor (Leu et al., 2008). 
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Besides, anti-apoptosis protein WSSV222 targets TSL, a shrimp tumor suppressor, by 
ubiquitination (He et al., 2006). 
Containing a RING domain, WSSV222 was characterized as a viral E3 
ubiquitin ligase (He et al., 2006). Its specific interaction with a tumor suppressor like 
protein (TSL) in shrimp results in ubiquitination and degradation on TSL, which has 
been studied in both mammalian and shrimp cells. WSSV222 functions as an anti-
apoptosis protein since it can rescue TSL-induced apoptosis in BHK cells based on 
ubiquitination-mediated degradation on TSL. However, in WSSV-infected shrimp, 
the function of WSSV222 and its requirement for efficient WSSV replication is not 
clear. Small interference RNA (siRNA) can induce specific gene-silencing in shrimp 
as a classical RNAi effect (Elbashir et al., 2002). This technique has been applied in 
different studies to silence the genes of WSSV to protect the shrimp from viral 
infection (Wang et al., 2008b; Westenberg et al., 2005; Xu, Han, and Zhang, 2007). 
In this context, the present study is aimed at to knock down the WSSV222 using 
specific siRNA to protect the shrimp from WSSV infection and the efficacy of anti-
WSSV222 was evaluated by determining survival rate of WSSV-challenged shrimp 













3.2 Materials and Methods 
3.2.1 Synthesis of siRNAs 
The sequence of siRNA used to silence WSSV222 was designed according to 
the design rule for RNAi using WSSV222 sequence (Elbashir et al., 2002). The 
sequence of the 222 siRNA is 5-GTGGAGTGTGTGCAACATC-3. For the control 
siRNA, the sequence of the 222 siRNA was rearranged at random and the sequence 
was designed as 5-GACGTAGTCTCGTGATGAG-3. The siRNA oligonucleotide 
was synthesized in vitro from Sigma and annealed according to the protocol reported 
previously (Elbashir et al., 2002). Briefly, both the sense and anti-sense RNA 
oligonucleotide are mixed with annealing buffer (Promega) at the final concentration 
of 40ug/ul. The annealing reaction is heated at 90°C for 3 minutes and 37°C for 15 
minutes. The annealed siRNA complex can be used immediately or stored at -20°C 
for up to one month. 
3.2.2 Shrimp culture, WSSV infection and siRNA injection 
Shrimp, Penaeus monodon, approximately 12 g in body weight  (around two-
month-old) were collected and screened for WSSV by PCR using WSSV-specific 
primers (Forward: 5’-TCGCCATCACTGCTGTGATTGC-3’ and Reverse: 5’-
CTTTGGCACCATCTGCATACC-3’). Natural seawater was used in all experiments 
and it was pumped from the adjacent sea to Singapore and further treated as described 
by Syed Musthaq et al. (Syed Musthaq et al. 2006). The animals were fed with 
artificial pellet feed (BTA feed, Malaysia). WSSV-negative shrimp (5 per group for 
the survival test) were stocked in individual 10-liter containers and acclimated for 2-3 
days prior to the experiment. The experimental shrimp were injected intramuscularly 
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at the 2nd abdominal segment with 222 siRNAs or random siRNAs at the dosage of 20 
µM in 100ul PBS per shrimp one day prior to WSSV challenge (Xu, Han, and Zhang, 
2007). For negative control, the shrimp were injected with NaCl (0.9%). The dosage 
of 103 or 106 virus copies per shrimp was used in the challenging experiments.  
3.2.3 In vitro silencing of WSSV222 
Sf9 cells (Invitrogen) were grown at 28°C in serum-free medium Sf-900 II 
SFM (GIBCO BRL) supplemented with 100 ug/ml gentamycin and transfected with 
siRNA by Effectene transfection reagent (Qiagen). Full-length WSSV222 gene was 
inserted into pFAST-HTa (Invitrogen) by SalI restriction site and EGFP gene was 
inserted by SalI and NotI sites. Recombinant baculovirus of WSSV222-EGFP was 
produced according to manufacturer’s instruction (Invitrogen). 
BHK cells were cultured in Dulbecco modified Eagle medium supplemented 
with 10% FBS at 37°C. Full-length WSSV222 gene was inserted into pEGFP-N1 
(Clontech) by BamHI and HindIII restriction sites. The cells were transfected with 
pWSSV222-EGFP (He et al., 2006) and anti-222 siRNA or unspecific siRNA 
(negative control) using Lipofectamine 2000 (Invitrogen) according to manufacturer’s 
instruction. The cells were observed under a fluorescence microscope at 24 h post-
transfection for gene expression or silencing.  
3.2.4 Reverse transcription PCR and Real time quantitative PCR   
Total RNA from head tissue of shrimp was extracted using Trizol reagent 
(Invitrogen) according to manufacturer’s protocol. After the treatment with DNase I, 
the RNA samples were stored in aliquots at –80 oC until further use. Genomic DNA 
was extracted with QiaAmp Minipre Kit (Qiagen). Subsequently, RT-PCR 
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amplification of WSSV222 and VP28 was performed with reverse transcriptase 
(Stratagene) according to manufacturer’s protocol as described before (Khadijah et al., 
2003). Briefly, a gene specific reverse primer was used in reverse transcription and 
nested PCR was employed for the gene amplification. Actin specific primers (5’-
GAGGTATCCTGACTCTCAAG- 3’ and  5’- GTCACACCATCACCAGTATC-3’) 
were also used as an internal control for RNA quality and amplification efficiency. 
The shrimp hemolymph was collected from the ventral sinus by inserting a 22-gauge 
needle containing heparin sodium (500 U/ml, pH 7.2) (Wang et al., 2008b) at 0, 3, 6, 
12, 24, 36, 48, 72 and 96 h post injection. Real time quantitative PCR was performed 
using the Master SYBR Green I system and LightCycler (Roche) as recommended by 
the supplier with cDNA or genome DNA from shrimp hemolymph. Primers 5’-
CCTACTACTAGCCAACAC-3’ and 5’-TGCAATTCATCTGGTACCAGGA-3’ 
were used to amplify WSSV222.  Primers 5’-TCGCCATCACTGCTGTGATTGC-3’ 
and 5’-CTTTGGCACCATCTGCATACC-3’ were used to amplify VP28.  A plasmid 
containing either WSSV222 or VP28 was used as a template in each real time 
quantitive PCR to standardize gene copies. 
3.2.5 Co-immunoprecipitation and western blot analysis  
Co-IP assays were performed with total protein extracted from shrimp 
hemocytes of different experimental shrimp groups. Protein samples were prepared 
with commercial protein extraction kit (Pierce). Briefly, anti-TSL antibody from 
mouse was incubated with protein A beads (Roche) at room temperature for 1h. The 
beads were washed and further incubated with protein samples at 4oC overnight. 
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Washed beads were then analyzed in western blot with anti-TSL antibody from 
guinea pig  (He et al., 2006). 
Western blot analysis was performed to determine protein expression in 
hemocytes with anti-TSL (He et al., 2006) or anti-actin monoclonal antibody (Santa 
Cruz). After separation on SDS–PAGE, the samples were transferred to 
polyvinylidene difluoride. After transfer, the membrane was blocked for 1 hour with 
5% bovine serum albumin. Blots were probed with a 1:1,000 dilution of primary 
antibodies followed by a 1:2,000 dilution of horseradish peroxidase-conjugated rabbit 
anti-mouse or anti-guinea pig immunoglobulin G (IgG; DAKO Cytomation) prior to 
development with the ECLTM Western blot substrate (GE healthcare). 
Mouse and guinea pigs were boosted three times with the same quantities of 
antigen emulsion for purified GST-TSL recombinant protein from E.coli every other 
day for 14 days. Ten days after the final booster injection, the animals were sacrificed 
by exsanguination and sera were collected. 
3.2.6 Fluorimetric assay of caspase activity 
Colorimetric assay of caspase-3-like (DEVDase) proteolytic activity was 
performed using an ApoAlert Caspase-3 Colorimetric Assay Kit (Clontech) and 
following the method described previously (Guo et al., 2003; Liu, Chen, and Kwang, 
2005). Shrimp hemocytes were harvested from 1ml hemolymph containing heparin 
sodium by centrifugation at 800g for 5min. Shrimp hemocytes were lysed in 50 ul of 
lysis buffer on ice for 10 min and centrifuged at 16 000g for 10 min, and the 
supernatant was collected. A 50 ul supernatant was added to an equal volume of 2x 
reaction/DTT buffer supplemented with caspase-3 substrate DEVD-AFC (50 uM) and 
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incubated at 37 ℃ for 2 h. The optical densities at 400 nm for caspase-3 were 
determined. The nanomoles of pNA released per hour were calculated from the 
standard curve. 
3.2.7 Statistical analysis  
Numerical data from three independent experiments were analyzed by one-
way ANOVA or Student’s t-test (Graphpad software) based on the mean and standard 
deviation of triplicate assays. The mean time to death was determined as arithmetic 


































3.3.1 WSSV222 silencing in cultured cells and WSSV infected shrimps. 
The siRNA-based WSSV222-silencing was primarily studied in BHK cells, 
which can support efficient WSSV222 expression, as observed in the previous study 
(He et al., 2006). After cotransfection of BHK cells with the siRNA and p222-EGFP 
vectors, the expression of 222-EGFP protein was checked and a marked reduction in 
EGFP fusion protein expression was noticed in cells transfected with the specific anti-
222 siRNA (Fig. 8A), compared with the random siRNA or no siRNA controls. The 
level of WSSV222 mRNA was quantified in the transfected cells by a 222-specific 
real-time RT-PCR assay, normalized to actin mRNA levels. A molar ratio of 10:1 for 
anti-222 siRNA to WSSV222 target specifically silenced WSSV222 expression by 
88%, whereas a 1:1 ratio resulted in only 37% silencing compared to the control 
without siRNA. In the presence of random siRNA, however, even at a 10:1 ratio, a 
silencing of only 17% was measured, while at 5:1 and 1:1 ratios there was no 
significant decrease in WSSV222 mRNA levels compared to the control without 
siRNA. These results indicate that the siRNA designed in the present work targeting 
WSSV222 can efficiently and specifically silence WSSV222 expression in vitro. 
To further test the effectiveness of anti-222 siRNA in insect cells, Sf9 cells 
were transfected with the specific anti-222 siRNA or random siRNA. At 24h post-
transfection, the cells were infected with recombinant baculovirus expressing 
WSSV222-EGFP fusion protein. A reduction in fluorescence intensity from 
WSSV222-EGFP was observed in the group treated with anti-222 siRNA by 
fluorescence microscopy (Fig. 8B), indicating the decrease in 222-EGFP expression. 
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Meantime, a decrease in 222-EGFP transcription of the 222 siRNA group was 
detected in a 222-specific real time RT-PCR. The results confirm the efficacy of 222-
specific siRNA in invertebrate cells and suggest its potential in the inhibition of viral 
infection. 
Based on the results of in vitro studies, an attempt was made to utilize anti-
222 siRNA to protect the shrimp from WSSV. The efficacy of anti 222 siRNA was 
evaluated in shrimp injected with 103 or 106 WSSV copies. Three shrimp were tested 
at each time point. As indicated in real time RT PCR, WSSV222 transcription is 
increasing in the entire process of WSSV infection with either virus dose (Fig. 9A). 
Further, the dose response of siRNA in shrimp was conducted by injections of 103 or 
106 virus copies with different concentrations of 222 siRNA in 100 ul PBS. In real-
time RT-PCR for WSSV222 with samples at 48 h post infection, the effects of siRNA 
were shown to be equivalent at 20 µM or 40 µM anti-222 siRNA (Fig. 9B). 
Meanwhile, the inhibitory effect declined rapidly at siRNA doses less than 20 µM, 
suggesting that the optimum concentration of anti-222 siRNA was 20 µM in each 
shrimp. Thus, the dosage of 20 µM 222 siRNA was used in further experiments. In 
RT-PCR, no WSSV222 mRNA expression could be detected in all of the shrimp with 
222 siRNA until 3 days after WSSV infection, while the WSSV222 transcription was 
clearly observed in the infected shrimp with random siRNA as early as 3 h post 
infection (Fig. 11A). This result confirms the silencing of WSSV222 by 222 siRNA 




















Fig. 8 Specific WSSV222 siRNA induces WSSV222 silencing in cultured cells. A). 
Visualization of WSSV222-EGFP expression in BHK cells after cotransfection with 
pWSSV222-EGFP and specific WSSV222 siRNA or random siRNA control. Images 
shown are for cells transfected at a 10:1 molar ratio of specific or random siRNA to 
the pWSSV222-EGFP target, taken at 24 h posttransfection using 24-well culture 
plates. DNA quantities for transfections were calculated based on the transfection of 
400 ng of pWSSV222-EGFP plasmid. B). Visualization of WSSV222-EGFP 
expression in Sf9 cells infected with recombinant baculovirus and transfected with 
specific WSSV222 siRNA or random siRNA control. Images shown are for cells, 
which were transfected with 1ug specific or random siRNA and infected at MOI. of 5, 
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Fig. 9 Specific WSSV222 siRNA induces WSSV222 silencing in WSSV 
challenged shrimp. A) WSSV222 transcription was quantitated by a 222 specific 
real-time RT-PCR during the infection time course. Shrimp were challenged with 
WSSV at the concentration of 106 or 103 copies. Each point represented the results of 
triplicate assays (mean ± SD). B) The effect of different concentrations of anti-222 
siRNA on the transcription of WSSV222 in WSSV-challenged shrimp. Shrimp were 
challenged with WSSV at the dose of 106 or 103 copies. Each point represented the 
mean of triplicate assays within ± 10% standard deviation. The samples were 












3.3.2 WSSV222 silencing delayed death time in WSSV infected shrimp 
In order to study WSSV222 function during WSSV infection, the mortality 
rate was compared among different experimental groups of shrimp. In the shrimp 
challenged with 106 copies of WSSV, 100% mortality reached within 4-6 day post 
infection (d p.i.) (Fig. 10A). However, the mean time to death in the group with 
WSSV222 silencing was 4.20 + 0.82 days, which was longer than either the WSSV 
control group (2.13 + 0.55 days) or the random siRNA group (3.46 + 0.60 days) (p 
<0.01). These data indicate that the knockdown of WSSV222 using 222 siRNA 
results in the delay of death of WSSV infected shrimp, though it could not rescue 
shrimp from death in the high WSSV dosage challenge.  
Further, WSSV challenge was also performed with a lower dosage of 103 
virus copies to fully reveal WSSV222 function. As shown in Fig. 10B, the mortality 
in WSSV infected shrimp decreased significantly with WSSV222 siRNA (53.33%), 
compared to either the no-siRNA (100%) or random siRNA (100%) groups (p <0.01). 
Besides, among those dead shrimp with 222 siRNA, the death of shrimp started as 
early as 5 d p.i., while the earliest death occurs at 4 d p.i. in random siRNA group and 
3 d p.i. in no siRNA group. Taken together, these studies indicate that WSSV222 
contributes to the severity of WSSV infection and suggest that WSSV222 silencing 





























































































Fig. 10 Efficacy of 222 siRNA in WSSV-challenged shrimp. A). Cumulative 
percent mortality of shrimp challenged with a high dose of WSSV (106 copies). B) 
Cumulative percent mortality of shrimp challenged with a low dose of WSSV (103 
copies). The 222 siRNA group had significantly lower mortality than either the no 
siRNA or the random siRNA groups (p < 0.01). 5 shrimps in each group and the 














3.3.3 Delayed and reduced WSSV replication in shrimp with WSSV222 silencing 
After the knockdown of WSSV222 expression in infected-shrimp, effects of 
222 siRNA on WSSV replication were investigated by RT-PCR using primers for 
WSSV VP28 gene which encodes the envelop protein VP28. In the random siRNA 
control group, VP28 mRNA was observed in WSSV-infected shrimp as early as 12 h 
p.i. and gradually increased in the following time points (Fig. 11A). Meanwhile, in 
the silencing of WSSV222 expression, VP28 mRNA expression was delayed and 
detected after 24 h p.i., suggesting WSSV replication was delayed due to WSSV222 
silencing. To further confirm this, the level of VP28 or WSSV222 mRNA was 
quantified in different groups by gene-specific real time RT-PCR (Fig. 11B). During 
WSSV infection, besides the delayed virus replication, a reduction in WSSV 
expression was also observed in the 222 siRNA group. As a DNA virus, WSSV 
copies in infected shrimp were also determined by a real-time PCR based on shrimp 
DNA templates (Fig. 11C). At 72 h p.i., in WSSV-infected shrimp, WSSV was 
quantified as 2.56+0.46 x107 virions per µl of hemolymph. A similar result was found 
in the random siRNA control group (2.21+0.59 x 107 WSSV virions/µl of 
hemolymph), while the copy number of virions decreased to 0.13+0.07 x107/µl 
hemolymph in the group with 222 siRNA. These results present delayed and reduced 
WSSV replication in shrimp treated with 222 siRNA, indicating that WSSV222 is 
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Fig. 11 WSSV222 silencing results in the delay and reduction of WSSV gene 
expression in shrimp challenged with WSSV (106 WSSV copies). A) RT PCR 
detection of VP28 and WSSV222 genes in shrimp challenged shrimp treated with 222 
siRNA or random siRNA at different time intervals. Shrimp actin was used as control. 
Total RNA samples were extracted from shrimp head tissues. B) WSSV gene 
expression was quantified by a VP28 or 222-specific real time RT PCR during the 
infection time course. Total RNA samples were extracted from shrimp hemolymph. 
The data were normalized based on the expression level of shrimp actin. WSSV 
expression was indicated in gene copies/ul hemolymph along the ordinate and the 
time points were shown along the abscissa. Three independent experiments were 
conducted (p<0.05). C) WSSV copies were quantified by a VP28-specific real-time 
PCR in WSSV-challenged shrimp treated with 222 siRNA or random siRNA. DNA 
samples were extracted from shrimp hemolymph 72h postinfection. WSSV 
replication was indicated in WSSV 107 copies/ul hemolymph along the ordinate and 
the solutions used for injections were shown along the abscissa. The experiments 
including the three independent experiments were conducted. (p<0.01) 
3.3.4 WSSV222 is required for TSL degradation in WSSV infected shrimp. 
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TSL is degraded by WSSV222 via the 26S proteosome pathway in 
mammalian cells, and co-IP with anti-TSL antibody was used to detect the expression 
of TSL in shrimp during WSSV infection. A reduction in TSL expression was 
observed in samples from WSSV infected shrimp when compared to uninfected 
shrimp. MG132 is an inhibitor of the 26S proteosome. Each shrimp was injected with 
20 µM of MG132 one day before infection. There was no reduction in TSL 
expression in MG132 treated shrimp after WSSV infection (Fig. 12A), confirming 
TSL degradation in WSSV infected shrimp. Based on this, effects on TSL expression 
in WSSV infected shrimp from WSSV222 silencing were further studied. As 
observed in the detection with anti-TSL antibody, less TSL degradation was detected 
in shrimp with the knockdown of WSSV222 during WSSV infection, while a 
decrease in TSL was observed in the random siRNA group. These results indicate that 
TSL degradation relies on WSSV222 expression (Fig. 12B). Taken together, we can 












Fig. 12. Co-immunoprecipitation and western blot showed TSL degradation in 
normal and WSSV-challenged shrimp treated with 20 uM MG132  (A), 222 
siRNA or random siRNA (B). Protein samples were extracted from shrimp 
hemolymph at 24h postinfection. Shrimp actin was used as normalization control. Co-
IP was performed with anti-TSL antibody from mouse and western blot was with 





















































3.3.5 WSSV222 contributes to the regulation on WSSV associated apoptosis in 
shrimp. 
To further study the effects from WSSV222 knockdown on cell apoptosis in 
shrimp, caspase-3 expression in shrimp hemocytes was quantified during WSSV 
infection (Fig. 13). At 24h postinfection (infection with 103 WSSV copies), increased 
caspase-3 expression was detected in all WSSV infected groups as compared with the 
mock group. With WSSV222 silencing, a higher increase in caspase-3 expression was 
observed, in comparison to either the no-siRNA or random siRNA group, suggesting 
that WSSV222 might contribute to the inhibition of host-induced apoptosis at the 
early stage of infection. However, at 72h postinfection, the caspase-3 level in shrimp 
with 222 silencing was significantly lower than the random siRNA group, as well as 
the no-siRNA group, though it is higher than the level detected in the 222 siRNA 
group at 24h postinfection. The phenomenon confirms that WSSV222 silencing 
relieves the viral severity in shrimp. These results indicate that the knockdown of 
WSSV222 has contradictory effects on shrimp apoptosis during different WSSV 












Fig. 13. WSSV222 silencing has effects on cell apoptosis in shrimp during WSSV 
infection. WSSV infection was performed with 103 virus copies per shrimp. 
Hemocytes were harvested at 24h and 72h postinfection, respectively. Caspase-3 















































In this study, we presented direct evidences for the requirement of WSSV222 
for efficient WSSV replication in shrimp. As described previously, WSSV222 is able 
to mediate degradation of a shrimp tumor suppressor and rescue TSL induced 
apoptosis in mammalian cells, suggesting that it antagonizes host induced apoptosis 
in shrimp during WSSV infection. The results of the present study indicated that the 
knockdown of WSSV222 expression in WSSV infected shrimps reduced the severity 
of White Spot disease, delayed WSSV replication, and recovered TSL expression. 
Our study further characterized the important role of WSSV222 in WSSV replication 
in shrimp tissue.            
During virus infection, apoptosis in host tissues plays two contradictory roles 
in viral pathogenesis (Tschopp et al., 1998). At the early stage of infection, especially 
in the initiation of infection, virus countermines host-induced apoptosis for efficient 
virus spreading and replication (Everett and McFadden, 1999). For example, human 
papillomavirus employs ubiquitination in the proteolytic removal of the tumor 
suppressor p53 (McLean et al., 2008; Stewart, Ghosh, and Matlashewski, 2005). 
Meanwhile, at the late stage, apoptosis enhances viral pathogenicity for successful 
virus budding and viral signal transduction (McLean et al., 2008; Rijiravanich, 
Browdy, and Withyachumnarnkul, 2008). Degradation of TSL after WSSV infection 
suggests the shrimp tumor suppressor TSL is involved in host-induced apoptosis for 
host protection against virus in the early stage of the infection. Such degradation was 
inhibited by WSSV222 silencing, together with the evidence for the early 
transcription of WSSV222 at 3h postinfection, suggesting that WSSV222 is an early 
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protein in WSSV. Furthermore, the silencing of WSSV222 delayed shrimp death and 
WSSV replication, making a strong implication that WSSV222 functions in the early 
stage of WSSV infection to inhibit host-induced apoptosis. Hence, in the WSSV222-
silenced shrimp, host-induced apoptosis could successfully proceed to the stage of 
shrimp protection due to the absence of WSSV222 mediated degradation on TSL. 
This process further prevents virus spreading to neighboring tissues and suspends 
virus replication, which could lead to the delay in the mortality and the reduction of 
WSSV replication as observed in the present study. Even though cell apoptosis is 
detected in shrimp in the early stage of WSSV infection, the number of apoptosic 
cells is much less than in the late stage. This reduction in apoptosis level could be 
caused by an antagonistic effect of WSSV222 against apoptosis. Besides, the anti-
apoptosis function of WSSV222 specially relies on the interaction between 
WSSV222 and TSL, as shown in this study. There could be other host-induced 
apoptosis machinery triggered by additional tumor suppressors, which cannot be 
inhibited by WSSV222. However, WSSV222-mediated ubiquitination on TSL 
effectively reduces the host-induced apoptosis in the early stage, paving the way for 
efficient virus replication. 
A newly-found shrimp caspase gene is believed to function like human 
caspase-3, which is one of the key executioners of the apoptotic process (Rijiravanich, 
Browdy, and Withyachumnarnkul, 2008; Wongprasert et al., 2007). Elevated caspase-
3 expression was associated with shrimp mortality from WSSV infection, supporting 
a link between caspase-induced apoptosis and death (Wongprasert et al., 2007). 
Therefore, the caspase-3 activity in shrimp hemocytes was employed to evaluate the 
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intensity of apoptosis in WSSV infected shrimp as studied in this report, elucidating 
the anti-apoptosis role of WSSV222. 
WSSV222 silencing reduced the mortality in shrimp challenged with a low 
dosage of WSSV and delayed the mean death time after a high-dosage challenge and 
this observation suggests that the protection by 222 siRNA against WSSV infection is 
mild. One reason is probably that the siRNA-based gene silencing does not support 
the permanent protection in shrimp, as suggested in the previous results (Wang et al., 
2008b; Xu, Han, and Zhang, 2007). The other possible explanation will be that 222 
siRNA has its limit and is able to protect the shrimp at the low level but not at the 
high level of WSSV infection. With an excess in the challenge dosage, 222 siRNA 
might block a part of WSSV222, but the leaky expression of WSSV222 eventually 
promotes virus replication and causes the shrimp mortality.  
A few viral proteins have been identified to promote ubiquitination in the host 
for pathogenesis, such as auxiliary regulatory protein Vpr in HIV-1 and the V 
proteins in simian virus 5 and human parainfluenza virus type 2 (Precious et al., 
2005a; Precious et al., 2005b; Zhao, Jian, and Zhu, 2004). The baculovirus inhibitor 
of apoptosis protein Op-IAP3 ubiquitinates pro-apoptotic cellular proteins as a viral 
E3 ligase (Green, Monser, and Clem, 2004). In WSSV, RING protein WSSV249 
sequesters ubiquitin conjugating E2s in shrimp and induces a increase in E2 
expression after infection (Wang et al., 2005), suggesting enhanced ubiquitination in 
WSSV infected shrimps. Here, with MG132 treatment, the proteosome inhibitor, TSL 
degradation is inhibited in WSSV infected shrimps, indicating TSL is regulated via 
the ubiquitin-26S proteosome pathway. Similarly, WSSV222 silencing prevents TSL 
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degradation in shrimp during infection, revealing that WSSV222 is required in this 
ubiquitin-mediated regulation on TSL. The results indicate that WSSV222 plays an 
important role in WSSV-induced ubiquitination in shrimp, which contributes to 
efficient WSSV replication and pathogenesis. 
It has been reported in a few studies that significant WSSV gene expression 
was detected in shrimp hemocytes with either immunostaining (Wang et al., 2008a; 
Wang et al., 2002) or RT-PCR (Wang et al., 2008b). Shrimp hemocytes were proved 
to be the major target for WSSV attachment (Liang et al., 2005; Sritunyalucksana et 
al., 2006) and the main source of WSSV harvest (Syed Musthaq et al., 2006; Wang et 
al., 2008b; Wang et al., 2002). Therefore, WSSV copy numbers in hemocytes from 
shrimp indicate the intensity of WSSV infection (Wang et al., 2008b). In addition, 
shrimp hemocytes could be easily isolated from shrimp hemolymph as pure and clean 
tissue samples without any contamination of foreign proteins or tissues, compared 
with other shrimp tissues. Hence, shrimp hemocytes have been widely used in WSSV 
and shrimp studies to accurately determine and quantify viral or cellular protein and 
gene expression (Lin et al., 2002; Sritunyalucksana et al., 2006; Wang et al., 2008a).  
In this study, considering these advantages, hemocyte samples were exploited to 
study TSL protein expression and WSSV gene transcription. So far, no continuous 
shrimp cell line has been established supporting WSSV replication in vitro. Some 
researchers reported that crayfish hemocytes fail to support WSSV replication as well 
(Shi et al., 2005). This is possibly caused by differences in the hemocyte origin (Arts 
et al., 2007) and current technological limitations. Therefore, this does not hinder the 
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employment of shrimp hemocytes as a useful cellular platform in those studies on the 
interaction and regulation of WSSV and its host. 
The present study showed an elucidation on WSSV222 function in shrimp, the 
susceptible species for WSSV, during WSSV infection by the siRNA-induced 
WSSV222 silencing. These findings provide a better understanding in viral anti-
apoptosis mechanism and alternative methods to inhibit WSSV in cultured shrimp. 
Further studies may be carried out to focus on TSL function in the host defense 



























Chapter 4  
Identification and characterization of 
WSSV403 as a viral E3 ligase involved in 




















In the past several years, studies of WSSV mainly focused on the viral 
structural proteins and more than 30 proteins matching WSSV ORFs have been 
identified as envelop proteins and collagen-like protein (Escobedo-Bonilla et al., 2008; 
Tsai et al., 2006; van Hulten et al., 2001b). Only a few non-structural genes have been 
characterized. A previous study has revealed the involvement of the RING finger 
domain in specific ubiquitination events by acting as the E3 ubiquitin protein ligase. 
Among these RING proteins from WSSV, WSSV222 mediates degradation on a 
shrimp tumor suppressor as a viral E3 ligase (He et al., 2006) and WSSV249, also 
acting as an E3 ligase, sequesters the shrimp E2 ubiquitin-conjugating enzyme (Wang 
et al., 2005). To fully display function of RING proteins in WSSV, here we focus on 
WSSV403, another viral E3 candidate. Studies performed here suggests that it is 
potentially involved in the regulation of WSSV latency. 
It has been suggested that WSSV can exist as an asymptomatic carrier state 
(Tsai et al., 1999). Certain stress conditions, such as collection, transportation, and 
poor water quality can induce carrier state to infective state and initiate the outbreak. 
shrimps are asymptomatic carriers of WSSV. Three latency-associated genes (LAG) 
were identified from specific-pathogen-free shrimp by microarray (Khadijah et al., 
2003). Although little is known about these three ORFs, it is interesting to 
characterize the role of LAGs in the viral life cycle – from latency to lytic replication. 
Among them, ORF89 was found to be a transcription repressor (Hossain, Khadijah, 
and Kwang, 2004) and WSSV427 can interact with a shrimp phosphatase (Lu and 
Kwang, 2004). Microarray has also been employed in WSSV studies to find out three 
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immediate early (IE) genes (Liu et al., 2005). At the molecular level, there is little 
understanding of how WSSV establishes latent infections or of the genes responsible 
for the transition between latent and lytic infection, which eventually leads to 
mortality. 
Specific-pathogen-free (SPF) shrimp are thought to lack WSSV before the 
three latency-associated genes were identified (Khadijah et al., 2003). 
Commercialized SPF shrimp (BIOTEC, Bangkok, Thailand) have been tested to be 
WSSV negative using an IQ2000 WSSV detection kit (Farming IntelliGene 
Technology Corporation). These shrimp have been grown for 6 generations in a 
controlled environment without any disease outbreak. Therefore, these SPF shrimp 
could be used as better research material for WSSV latency study without WSSV 
contamination compared with normal asymptomatic shrimp, especially in those 
highly-sensitive methods, such as Real time PCR, which could be used to 
differentiate latency-assoicated genes from normal genes (Khadijah et al., 2003). 
Meanwhile, visible symptoms will take place in normal shrimp due to environmental 
stress rather than virus contamination, raising the possibility that these shrimp contain 
WSSV in a dormant state (Chen et al., 2000a; Magbanua et al., 2000; Okumura et al., 
2005). In this study, both of normal shrimp and these SPF shrimp were used to study 








4.2 Materials and Methods 
4.2.1 Reverse transcription PCR and real time PCR.  
Healthy adult P.vannamei weighing around 15 g was verified to be free of 
WSSV by RT-PCR with primers for VP28 prior to infection. Total RNA from head 
tissue of four healthy and four infected shrimp was extracted using Trizol reagent 
(Invitrogen) according to the manufacturer’s protocol. After treatment with DNase I 
the RNA samples were stored in aliquots at –80 oC until further use. Subsequently, 
RT-PCR amplification of WSSV403 was performed with reverse transcriptase 
(Stratagene) according to the manufacturer’s protocol as described before (Khadijah 
et al., 2003). β-actin specific primers were used as a normalization control for RNA 
quality and amplification efficiency. Real time PCR was performed using the RNA 
Master SYBR Green I system and LightCycler (Roche) as recommended by the 
supplier. 
4.2.2 Expression, purification of proteins and antibody preparation.  
WSSV403 and 403RING were ligated to pQE30 (Qiagen) using BamHI and 
SalI sites for construction of expression plasmids. PPs was cloned into pGEX-4T3 
vector. 403-transformed E. coli M15 (pREP4) cells were cultured in LB with 
ampicillin (200 µg/ml) at 16ºC and induced with 1 mM isopropyl-1-thio-β-D-
galactopyranoside (IPTG), while the one of PPs (protein phosphatase) was cultured at 
37 ºC. Bacteria were harvested by centrifugation, resuspended in lysis buffer (New 
England Biolabs) and lysed by sonication. The expressed proteins were then bound to 
Ni-NTA beads (New England Biolabs) or GST beads. The purified protein-
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conjugated beads were then denatured in Laemmli sample buffer prior to SDS-PAGE 
on a 12% gel and subjected to Western blot.  
Guinea pigs were boosted three times with the same quantities of antigen 
emulsion for WSSV403 every other day for 14 days. Ten days after the final booster 
injection, the animals were sacrificed by exsanguination and sera were collected. 
4.2.3 Pull-down assays.  
Cell lysate from WSSV403-expressing E.coli was incubated with purified 
GST-PPs or GST protein (negative control) at 4ºC for 2h. The mixtures were clarified 
by centrifugation at 1500 ×g for 10 min, supernatants incubated with fresh GST 
beads, and then washed in ice-cold wash buffer (100 mM Tris-HCl [pH 8.0], 150 mM 
NaCl, 5% glycerol, 0.1% Nonidet P-40, 5 mM β-mercaptoethanol) five times at 4ºC. 
The beads were then denatured in Laemmli sample buffer prior to SDS-PAGE and 
immunoblotting with anti-His6 and anti-GST antibodies respectively. 
4.2.4 Ubiquitination assays in vitro.  
E1 and E2 enzymes used in this experiment were purchased from Boston 
Biochem. In vitro ubiquitin conjugation assays were performed in a buffer containing 
50 mM Tris-HCl (pH 7.5), 5 mM MgCl and 2 mM ATP. The concentration of protein 
and enzymes used were as follows: 50 nM E1, 250 nM E2, 5 µg ubiquitin (Sigma), 
approximately 200 ng of E3 ligase. After 4 h incubation at 30ºC the reactions were 
quenched with Laemmli sample buffer and subjected to electrophoresis on a 10% 
SDS-polyacrylamide gel. Proteins were transferred to a nitrocellulose membrane for 
immunoblotting and then probed sequentially using anti-ubiquitin monoclonal P4D1 
(1:1000; Santa Cruz Biotechnology) and horseradish peroxidase conjugated rabbit 
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anti-mouse immunoglobulin G (IgG; 1:1000) for in vitro assays. Bound antibody was 
detected using enhanced chemiluminescence reagent (Pierce) and exposure on film.  
4.2.5 Yeast two-hybrid assays.  
Two-hybrid assays were performed using the Matchmaker GAL4 kit 
(Clontech). Growth conditions, media, and transformation protocols were as 
described by the manufacturer. The bait construct pGBKT7-403 and the shrimp 
cDNA library in pGADT7 were used to cotransform yeast strain AH109. 
Transformants were selected for growth on –His/–Leu/–Trp dropout medium. The 
selected colonies were then transferred to –Ade/–His/–Leu/–Trp plates containing 
250 µl X-α-gal (2 mg/ml in DMF, Genomax) per 15 cm plate. Blue colonies were 
selected and cultured in –Ade/–His/–Leu/–Trp broth and lysed with glass beads 
(Sigma) for plasmid isolation in lysis buffer (2% Triton X-100, 1% SDS, 100 mM 
NaCl, 10 mM Tris-HCl, pH 8.0, 1 mM EDTA). Isolated plasmids were amplified in E. 
coli DH5α and the target insertions verified by sequencing. Target and bait plasmids 











4.3.1 WSSV403 is a RING-H2 E3 ligase. 
The full-length WSSV403 was cloned from WSSV DNA, encoding a protein 
of 641 aa. An initial characterization of the putative protein encoded by WSSV 
ORF403 (AF332093) revealed the presence of a RING finger domain similar to those 
from WSSV222 and WSSV249 (Fig. 1). The presence of a C3H2C3-type RING 
finger suggested that WSSV403 belongs to the RING-H2 subgroup and could be 
involved in ubiquitination. To focus on this RING domain, a RING-containing 
fragment named 403RING was cloned from WSSV403. 403RING protein (211-494aa) 
was expressed in E.coli by pQE vector (Qiagen) as well as full-length WSSV403 (Fig. 
14A). The His6-tagged proteins were detected by Western Blot with anti- His6 
antibody (Qiagen) and purified for in vitro ubiquitination assays as previously 
described (Wang, 2002). To determine if WSSV403 possessed ubiquitination activity 
in vitro and which, if any, E2 enzyme stimulated this activity, purified 403RING was 
incubated with a range of different E2 enzymes, including a shrimp E2 Pvubc (Wang, 
2002), in the presence of E1, ubiquitin and ATP. Among these E2s we used, 
403RING can be strongly activated as an E3 ligase by Pvubc, ubcH3, ubcH5a, 
ubcH5c and ubcH6 (Fig. 14B), indicating that 403RING can support E3 ligase 
activity and display a low degree of E2 specificity. Besides 403RING, with Pvubc, 
the full-length WSSV403 can also be polyubiquitinated by itself (Fig. 14C), 
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Fig. 14. WSSV403 is a viral E3 ubiquitin ligase. (A) Both full-length WSSV403 
and 403RING can be expressed in E.coli with pQE vector and expression is 
confirmed by Western blot with anti-histidine antibody. 1: Total cell lysate from un-
induced E.coli; 2: Total cell lysate from E.coli expressing 403RING; 3: Total cell 
lysate from E.coli expressing WSSV403. (B) A panel of different E2 enzymes was 
screened for activity in the presence of 403RING. The negative control reaction was 
performed in the absence of E2. -E2: negative control without E2 conjugating enzyme; 
sE2: shrimp E2 Pvubc; 5a, 5b, 5c, 6, 9 and 12: Ubc 5a, Ubc5b, Ubc5c, Ubc6, Ubc 9 
and Ubc 12 are variant E2 enzymes from human. (C) In vitro conjugation assay using 
anti-WSSV403 and anti-ubiquitin antibody P4D1. WSSV403 can be 






4.3.2 WSSV403 is a latency-associated gene. 
To further study this viral E3 ligase with WSSV, a time course RT-PCR was 
performed with WSSV-infected shrimp RNA for WSSV403 using methods described 
before (Wang, 2002). WSSV403 transcription was detected in all of WSSV-inoculated 
samples. And mRNA expression of WSSV403 gradually increases after WSSV 
inoculation. Surprisingly, from normal shrimp RNA sample without WSSV 
inoculation, WSSV403 transcript was also found (Fig.15A). This result suggests the 
potential role of WSSV403 in latency. Moreover, SPF shrimp samples were tested in 
RT-PCR for WSSV403 expression. With the three identified latency-associated genes, 
WSSV151, WSSV366 and WSSV427 (Khadijah et al., 2003), as positive controls, two-
step PCR was employed to amplify WSSV403 gene from SPF shrimp cDNA (Fig. 
15B). Primers for full-length WSSV403 were used in the first step of the PCR and 
nested PCR was then performed using primers for 403RING. The amplicon for 
WSSV403 was purified and sequenced for confirmation. Meanwhile, two other genes, 
VP19 and VP28, were used as negative controls in this two-step PCR. To further 
verify this result, SYBR Green real-time RT-PCR was done to identify WSSV403 in 
SPF shrimp. Here, a specific primer for WSSV403 was used in reverse transcription of 
the SPF shrimp RNAs. cDNA from this reverse transcription was further used as the 
template for Real time PCR. WSSV DNA and WSSV-infected shrimp cDNA were 
included to this experiment as positive controls. WSSV403 was amplified by this 
approach (Fig. 15C), indicating that WSSV403 is a latency-associated transcript for 
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Fig. 15. Detection of WSSV403 transcript in shrimp. (A) WSSV403 transcription 
was detected in shrimp during WSSV infection by time course RT-PCR. WSSV403 
transcription was detected in shrimp before WSSV inoculation. (B) WSSV403 
transcript was found in SPF shrimp RNA by nested RT-PCR. Three latency-
associated-genes, WSSV151, 366 and 427, were indicated as positive controls, while 
VP19 and VP28 were used as negative controls. (C) Amplification profiles and 
dissociation curves of WSSV403 in real time PCR using WSSV DNA, total RNA 
from WSSV-infected shrimp and amplified RNA from SPF shrimp. Water was used 









4.3.3 WSSV403 interacts with shrimp phosphatase. 
To understand better this new latent gene of WSSV, yeast two-hybrid was 
performed with WSSV403 as a bait to screen shrimp cDNA library according to 
procedures described previously (He et al., 2006). Among 15 clones we obtained on 
high-stringent plates, by DNA sequencing, 4 clones were found to encode a protein 
phosphatase which was identified in our laboratory before (Lu and Kwang, 2004). 
Plasmids extracted from these yeast clones were retransformed to yeast for 
verification. Blue colonies appeared on high-stringent plates with x-α-gal (Fig. 16A, 
B), indicating WSSV403 can interact with shrimp protein phosphatase in yeast. To 
further investigate this phenomenon in vitro, pull-down assays were performed by 
proteins expressed in E.coli. Total cell lysates from E.coli expressing GST-PPs or 
His6-WSSV403 was mixed and incubated at room temperature for 2h. The reaction 
mixture was clarified by spinning and the supernatant was collected and incubated 
with GST beads. Protein complex eluted from GST beads was tested by Western blot 
with anti-his6 antibody. Figure 16C showed that WSSV403 tagged with His6 was 
detected in samples from GST-PPs, while it was absent in the control test of GST 
only, indicating WSSV403 can specifically interact with PPs. This result further 
confirms the physical interaction between WSSV403 and shrimp protein phosphatase. 
Interestingly, the same shrimp PPs can interact with WSSV427 (Lu and Kwang, 
2004), another latency-associated protein in WSSV, implying that all of the three 












Fig. 16. WSSV403 can interact with a shrimp protein phosphatase. WSSV403 
was found to interact with shrimp PPs in yeast two hybrid. Cotransformed yeast was 
screened on -Leu-Trp SD plates (A) and -Leu-Trp-His-Ade plates with x-α-gal (B). 1, 
yeast cotransformed with pGBK-403 and pGAD-PPs; 2, yeast cotransformed with 
pGBK-403 and pGAD; 3, yeast cotransformed with pGBK and pGAD-PPs; 4, yeast 
cotransformed with positive plasmids from the kit (Clontech). (C) Pull-down assays 
with WSSV403 and GST-PPs. Soluble protein complexes were bound to GST beads 
and washed under high stringency condition before SDS-PAGE and immunoblot 




Viral latency, which is defined operationally as the persistence of the viral 
genome without production of infectious virions, but with the potential to be activated 
under certain stimuli, happens in several DNA viruses, such as human 
cytomegalovirus (Sinclair and Sissons, 2006) and Epstein-Barr virus (Leight and 
Sugden, 2000). Here, one novel latency-associated transcript was identified from SPF 
shrimp during our studies on RING-containing proteins from WSSV. And its viral 
gene expression was detected in normal shrimp tissue. Taken together with the other 
three latency-associated-genes of WSSV found previously (Khadijah et al., 2003), 
this report further verifies that viral gene transcription takes place in asymptomatic 
shrimp, and suggests that WSSV genome is present in SPF shrimp and WSSV latent 
infection takes place in its host tissue.  
Though some latency-associated genes can inhibit virus lytic stage to maintain 
virus latency, such as latent gene vFLIP from Kaposi's Sarcoma-Associated 
Herpesvirus (Ye et al., 2008), some other ones contribute to the transit between the 
latent and lytic stage. For example, the latency-associated transcript gene of herpes 
simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation 
of HSV-1 from latency based on its anti-apoptosis function (Perng et al., 1994; Perng 
et al., 2002). In our studies, WSSV403 transcription takes place in normal shrimp 
during the potential latency of WSSV and increases once the lytic stage starts. This 
finding suggests that WSSV403 expression should contribute to the activation of lytic 
stage. And such function of WSSV403 could be repressed by certain factors during 
the virus latent stage, one of which is probably the protein phosphorylation. 
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The interaction between WSSV403 and shrimp protein phosphatase allows 
WSSV403 to be a regulator of latent and lytic infection of WSSV, since the 
regulation on such kind of proteins by protein phosphatases has been implicated in 
the latent-lytic life cycle for some other model viruses. In herpes simplex virus, 
inhibition of protein phosphatase 2B results in a increase in the amount of the 
regulatory protein ICP0, which leads to efficient virus replication (Chen et al., 2000). 
The switch from latency to viral replication of Epstein-Barr virus is mediated by Zta, 
the protein product of EBV gene BZLF1. And transcriptional activation of the BZLF1 
promoter is greatly augmented by the Ca2+/calmodulin-dependent phosphatase 
calcineurin (Chatila et al., 1997). Here, for the interaction between WSSV403 and 
shrimp PPs, one possibility is that the WSSV403 function depends on its 
phosphorylation status regulated by the shrimp PPs. WSSV403 E3 function could be 
activated by dephosphorylation with shrimp PPs. This could lead to WSSV403- 
mediated ubiquitination on other host proteins in downstream in order to trigger virus 
replication. 
Further, ubiquitination plays important role in viral latency regulation. For 
example, RING protein ICP0, a regulator of herpes simplex virus during lytic and 
latent infection, is well-characterized as an E3 ligase (Canning et al., 2004). Latent 
membrane protein 2A of Epstein-Barr virus utilizes ubiquitin-dependent processes to 
modulate cellular signaling pathways involved in latency regulation (Portis, Ikeda, 
and Longnecker, 2004). As a RING-containing E3 ubiquitin ligase, WSSV403 is able 
to interact with its substrates besides E2 conjugating enzymes and to mediate 
degradation of the substrate, which enables it to regulate other proteins in 
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downstream via ubiquitination pathway. Thus, another model for WSSV403 involved 
in WSSV latency regulation could be that shrimp PPs is the potential substrate for 
WSSV403 in ubiquitination. WSSV403 could down-regulate shrimp PPs via 
ubiquitin-mediated degradation. This reaction could inhibit PPs-mediated 
dephosphorylation on other viral or host proteins in down-stream, which could be 
WSSV427. In WSSV, latency-associated protein WSSV427 is another interaction 
partner for the shrimp PPs (Lu and Kwang, 2004), indicating the systematic 
regulation between viral latent proteins and host proteins.  
The study of shrimp viruses has been hampered by the lack of a reliable and 
convenient in vitro cell culture system (Tapay et al., 1997). In an attempt to establish 
a expression platform in invertebrate species for WSSV studies, WSSV IE1 promoter 
has been employed in recombinant baculoviruses for WSSV protein expression (Lu 
and Kwang, 2005). This method could provide a solution to the lack of shrimp cell 
lines. Therefore, the detailed relation of WSSV403, the shrimp protein phosphatase 
and WSSV427 during WSSV latency and infection in shrimp will be further explored 
in future studies with any acceptable shrimp or other invertebrate cell culture models. 
This study identified RING protein WSSV403 as a candidate of latency regulator, 
which paves the way for clarifying the mechanism of the transit from latency to lytic 















Chapter 5  
 WSSV IE1 promoter is more efficient than 
CMV promoter to express H5 hemagglutinin 















The worldwide outbreak of influenza A (H5N1) viruses among poultry species 
and humans highlighted the need to develop efficacious and safe vaccines for farmed 
animals based on efficient and scaleable production.  
White spot syndrome virus (WSSV) immediate-early promoter one (IE1) was shown 
in luciferase assays to be a stronger promoter for gene expression in insect cells 
compared with Cytomegalovirus immediate-early (CMV) promoter. In an attempt to 
improve expression efficiency, a recombinant baculovirus was constructed expressing 
hemagglutinin (HA) of H5N1 influenza virus under the control of WSSV IE1 
promoter. HA expression in SF9 cells increased significantly with baculovirus under 
WSSV IE1 promoter, compared to CMV promoter, based on HA contents and 
hemagglutination activity. Furthermore, immunization with H5 expressing 
baculovirus under WSSV IE1 promoter in chickens elicited higher anti-HA antibody 
levels than under CMV promoter, as indicated in hemagglutination inhibition, virus 
neutralization and enzyme-linked immunosorbent assays. Strong HA antigen 
expression was observed by immunohistochemistry in different chicken organs after 
vaccination of WSSV IE1 promoter controlled baculovirus, confirming higher 
efficiency in HA expression by WSSV IE1 promoter. 
The production of H5 HA by baculovirus was enhanced with WSSV IE1 
promoter, especially compared to CMV promoter. This contributed to effective 
elicitation of HA-specific antibody in vaccinated chickens. This study provides an 
alternative choice for baculovirus based vaccine production. 
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5.2 Introduction 
The spread of highly pathogenic avian influenza A (H5N1) viruses from Asia 
to the Middle East, Europe, and Africa poses the threat of an influenza pandemic. 
Vaccination of poultry is an effective measure to control virus spread (Lipatov et al., 
2004). Production of inactivated influenza vaccine requires high-level biocontainment 
facilities and large numbers of embryonated chicken eggs, while baculovirus surface 
display of recombinant hemagglutinin may be an attractive alternative to the current 
influenza vaccine (Crawford et al., 1999; Laver and Webster, 1976; Safdar and Cox, 
2007; Swayne et al., 2000). 
White spot syndrome virus (WSSV), a major pathogen in shrimp, can infect a 
wide range of invertebrate tissues and cells. The WSSV genome has 9 repeated 
regions similar to those of baculovirus, suggesting the potential to exploit WSSV 
promoters in baculovirus and insect cell expression system (van Hulten et al., 2001a; 
Yang et al., 2001). Baculovirus produces high yields of foreign soluble protein in 
insect cells and mediates efficient transduction of mammalian cells. Thus, it is widely 
used as a vaccine production system (Yang et al., 2007). WSSV IE1 promoter was 
reported as one of the strongest promoters in insect cells (Liu et al., 2005; Lu, 2005). 
However, no documented report has compared the activity of WSSV IE1 promoter 
with other promoters in vaccine production. In this study, recombinant baculoviruses 
were constructed under WSSV IE1 promoter, in an attempt to establish a novel 
platform for efficient antigen expression. These recombinant baculoviruses were 
further evaluated in the hemagglutinin production of H5N1 influenza virus. 
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The influenza virus HA glycoprotein has receptor-binding activity and 
mediates viral-endosomal membrane fusion during viral entry and serves as the 
primary target for neutralizing antibodies (Bosch et al., 1979; Kawaoka and Webster, 
1988). HA protein from H5N1 influenza virus expressed in baculovirus mediated by 
WSSV IE1 promoter can be displayed on baculovirus surface without disrupting its 
authentic cleavage, hemagglutination activity and immunogenicity (Lu, Yu, and 
Kwang, 2007). Besides, baculovirus pseudotyped with the vesicular stomatitis virus 
glycoprotein (VSV G) emerges as a promising gene-delivery vector by virtue of its 
capability in transducing numerous mammalian cells (Pieroni, Maione, and La 
Monica, 2001; Tani et al., 2003). Coexpressed with VSV G in baculovirus, the HA 
protein could be delivered into host cells to elicit immune response in a long term. 
For the efficient HA delivery to target cells, an active promoter is required in both 
vertebrate and invertebrate species. 
The current study compared WSSV IE1 promoter with CMV promoter in the 
context of baculovirus vector for the efficient expression of HA protein from H5N1 
influenza virus as a surface-displayed immunogen in SF9 (Spodoptera frugiperda) 
cells. Further studies on immunogenicity were performed for these baculovirus 
vaccines under WSSV IE1 promoter in chickens. The results demonstrated that HA of 
H5N1 influenza virus could be more efficiently produced by baculovirus with WSSV 
IE1 promoter, which serves as a safe vaccine in chickens and provides effective 
immune protection from avian influenza.  
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5.3 Materials and Methods 
5.3.1 Viruses and cells.   
VNH5N1-PR8/CDC-RG obtained from Center for Disease Control (USA) is a 
non- pathogenic H5N1 influenza virus. PR8 strained-based reassortant virus 
comprises of the HA and NA gene of AIV H5N1 virus infecting human in Vietnam 
(A/Vietnam/1203/04). The virus was grown in the allantoic cavities of 10-day-old 
embryonated eggs (Chew’s Poultry Farm, Singapore).  
Madin-Darby canine kidney (MDCK) cells and African green monkey cell line (Vero) 
were obtained from American Type Culture Collection (ATCC) and grown in DMEM 
containing 10% FBS at 37oC with 5% CO2.  Spodoptera frugiperda pupal ovarian 
(SF9) cells (Invitrogen) were grown at 28 oC in serum-free medium Sf-900 II SFM 
(GIBCO BRL) supplemented with 100 µg/ml gentamycin and transfected with 
Effectene transfection reagent (Qiagen). Primary chicken embryo fibroblasts (CEF, 
prepared from specific-pathogen-free chicken embryo, Chew’s Poultry Farm, 
Singapore) were cultured in RPMI 1640 (GIBCO BRL) medium supplemented with 
10% fetal bovine serum and 100 µg/ml penicillin and 100µg/ml streptomycin at 37 oC 
under a 5% CO2 atmosphere.  
5.3.2 Luciferase activity assay 
Renilla luciferase activity was measured with the Dual-Luciferase Reporter 
Assay System (Promega, Madison, WI) according to the protocol (Technical Manual, 
#TM040) using a Luminometer (Berthold, Lumat LB 9507, ITS Science & Medical 
PTE LTD) (Hossain, Khadijah, and Kwang, 2004). DNA was isolated from WSSV-
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infected shrimps using DNeasy tissue kit (Qiagen). Luciferase reporter plasmids were 
constructed by inserting WSSV IE1 promoter into KpnI-Hind III sites of phRL vector. 
Vector pRL-SV40 and pRL-CMV were provided in the kit. Cells were lysed in 1 × 
lysis buffer (50 µl/well) for 15 min at room temperature and each cell lysate was 
added into the luminometer tube containing 100 µl of assay reagent. The mixture was 
mixed quickly by flicking for 2 s, and placed in the luminometer for 10 s 
measurement. Transfection efficiency was normalized using pRL-SV40 in Vero cells, 
in which SV40 promoter drives the firefly luciferase reporter gene. Data (mean + SD) 
were collected from triplicate assays of three independent transfections. 
5.3.3 Construction of recombinant baculoviruses 
For the generation of the recombinant baculovirus vectors, as mentioned 
before (Lu, Yu, and Kwang, 2007), AcMNPV polyhedrin promoter-controlled 
vesicular stomatitis virus glycoprotein  (VSV G) (Bailey et al., 1989) expression 
cassette and WSSV IE1 promoter or CMV promoter-controlled HA expression 
cassette (Figure 1) were inserted into the shuttle vector pFastBac1 and integrated into 
the baculovirus genome within DH10BACTM according to the protocol of Bac-To-
Bac system (Invitrogen). HA gene in our study was amplified from a Vietnam strain 
(A/Vietnam/1203/04/H5N1) with the multibasic HA cleavage site in a standard PCR 
method (94 oC 20sec, 55 oC 30sec and 72 oC 2 min for 30 cycles). CMV-HA cassette 
was amplified with a primer set of 5’ 
ACGCTACGTATAGTTATTAATAGTAATCAA 3’ and 
5’ACGTGCGGCCGCTTAAATGCAAATTCTGCATTGTAACGATC3’ from vector 
pCMV-EGFP (BD clontech) with HA gene. CMV promoter in the vector is Human 
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cytomegalovirus (CMV) immediate early promoter without intron. The CMV-HA 
cassette was inserted into pFastBac1 at the SnabI-NotI site. HA was also inserted into 
pFastBac1 vector with polyhedrin promoter at the NotI-SalI site to generate vAc-pol-
HA recombinant baculovirus. 
5.3.4 Recombinant baculovirus purification 
Infected SF9 cells with individual recombinant baculoviruses were harvested 
at 96h postinfection and subjected to freeze-thaw cycles for cell lysis. The cell lysate 
was spinned at 1000g for 5 minutes to remove cell debris. From the supernatant, the 
virus was purified by sucrose gradient ultracentrifugation following standard 
protocols (Yang et al., 2007) and the purity was determined by SDS-PAGE. Virus 
titer was determined in standard plaque assays with SF9 cells according to 
baculovirus construction protocol (Invitrogen, No.10359). Hemagglutinin contents in 
purified virions were estimated by densitometric analysis of stained gels following 
electrophoresis with Quantity One software (Bio-Rad). 
All of the baculoviruses were used without inactivation. As a control of 
protein vaccine, H5N1 (VNH5N1-PR8/CDC-RG) strain was inactivated with 0.3M 
BEI (binary ethylenimine) incubated at 37 oC overnight, according to the previous 
protocol (King, 1991). 
5.3.5 Animal experiments 
14-day-old chickens (Chew’s Poultry Farm, Singapore) received two doses of 
vaccines or PBS at intervals of 14 days by intramuscular injection or intranasal 
inoculation. 5 chickens were in each group. Each chicken was vaccinated with 
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purified live baculoviruses without adjuvant at the dose of 109 PFU based on virus 
copies (100ul, 1010 PFU/ml), or with influenza virus without adjuvant at the dose of 6 
ug based on HA content or 105 TCID50 based on infectivity. The sera were collected 
two weeks after each vaccination for evaluation. Chickens were killed for dissection 
two weeks after the second vaccination.  
Approval for the animal experiments was obtained from Institutional Animal 
Care and Use Committee in Temasek Life Sciences Laboratory, Singapore (the 
approved project number TLL-07-007). 
5.3.6 Serological assays 
To inactivate non-specific inhibitors, chicken sera were treated with receptor 
destroying enzyme (RDE, Sigma) by incubation at 56 oC for 30 min. 
Hemagglutination inhibition (HI) tests were carried out in microtitre plates with 1% 
suspension of chicken red blood cells. For neutralization tests, 2 x 104 /ml of MDCK 
cells were allowed to grow to 70% -90% of confluence. Allantoic fluids with 
H5N1(VNH5N1-PR8/CDC-RG), using a series of dilutions factors from 10-1 to10-8, 
were tested for TCID50. Using Reed and Muench mathematical technique(Grimes, 
2002), the infectivity titer was expressed as TCID50/100µl and the viruses (VNH5N1-
PR8/CDC-RG) were diluted to having 100 TCID50 in 50µl. After which, 100 TCID50 
viruses were incubated with chicken serum for 1 h at 37 oC and inoculated into 
MDCK cells. The cells were then incubated at 37 oC and CPE was observed at 96h 
post-infection. Besides, a cell-based ELISA were performed to determine 
neutralization titer according to standard procedures (Rowe et al., 1999). Guinea pigs 
were immunized with a live non-pathogenic virus (VNH5N1-PR8/CDC-RG) at 6ug 
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of HA contents and bled after two injections. The guinea pig IgG was purified from 
serum using protein A affinity column (Sigma, USA) in accordance with 
manufacturer’s instructions. Enzyme-linked immunosorbent assays (ELISA) were 
performed by antigen-capture methods with purified anti-H5N1 IgG from guinea pig 
(150ng/well) as capturing antibody. The plate was then incubated with purified virus 
(VNH5N1-PR8/CDC-RG) as antigen. The chicken serum samples were added and 
anti-chicken IgG secondary antibody HRP (Sigma, 1:3000) was used to develop 
signals with OPD substrate (Sigma, 1 tablet in 20ml water).  
5.3.7 Immunofluorescence assays 
SF9 cells were infected with HA-expressing baculovirus. They were fixed at 3 
days post-infection with 100µl of absolute ethanol for 10 minutes at room 
temperature. Cells in 96- well plates were then washed 3 times with PBS, pH 7.4. 
Subsequently, the fixed cells were incubated with 50µl of anti-H5 (He et al., 2007) or 
anti-VSVG monoclonal antibody (Sigma) for 1hr at 37 oC. After 3 washings, the 
antigens were incubated with fluorescein isothiocyanate (FITC)- conjugated anti-
mouse Ig (1:100 DAKO, Denmark) for 1h at 37oC. The cells were observed under 
fluorescence microscope. 
5.3.8 Immunohistochemistry 
Chickens were dissected after 2 weeks from the second vaccination and a 
series of organ tissues were collected, including brain, kidney, liver, lung and spleen. 
They were in the form of frozen sections. Commercially available immunoperoxidase 
staining system (Dako Cytomation EnVision + System-HRP (AEC)) was used for 
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these specimens according to instructions in the kit. This is a two- step staining 
technique(Renee Larochelle, 1995) to recognize bound antibodies(Tanaka et al., 2003) 
based on a horseradish peroxidase labeled polymer which is conjugated with 
secondary antibodies.  
5.3.9 Statistical analysis 
Welch's t test, which is the two-sample t-test that does not assume equal 
variances between groups, was performed to determine the level of significance in the 
difference between means of two groups (GraphPad, Software). One way ANOVA 
was performed by using ANOVA test calculator (Danielsoper, Software) online and 
the level of significance of difference in multiple comparison was determined 
according to Bonferroni adjustment (α=0.05) for multiple comparisons if applicable. 
















5.4 Results  
5.4.1 WSSV IE1 promoter mediates efficient protein expression in SF9 cells. 
In order to investigate whether the relative strength of the promoter was cell 
type dependent, a plasmid containing WSSV iel promoter (phRL-IE1) for luciferase 
expression was transfected into CEF and SF9 cells to test luciferase activity, in 
comparison to CMV (phRL-CMV). Luciferase activity, indicating intracellular 
luciferase quantity, was presented in folds of the basic value set in the system. Hence, 
a link was established between promoter activity and luciferase activity. SV40 
promoter was used as a control promoter in both insect and mammalian cells. Vero 
cells were used to normalize transfection efficiency. CMV promoter activity (mean 
87 folds, SD 5.3) was much weaker than the WSSV iel promoter (mean 1610 folds, 
SD 26.4) in SF9 cells. In CEF cells, the WSSV iel promoter activity (mean 6195 folds, 
SD 156.8) was slightly less than the CMV (mean 12715 folds, SD 258.8) (Fig 17). 
The data indicated that the WSSV iel promoter activity was strong in insect cells, in 
which CMV promoter activity was weak. Furthermore, WSSV IE1 promoter was 
found to be active in all of the vertebrate cells tested here, including human TK−143b, 
monkey Marc145, Vero, porcine PK15 and carp epithelioma papillosum (EPC) (data 
not shown). This property of WSSV IE1 promoter renders it a promising candidate 

























































































Fig. 17. Comparison of promoter activity of WSSV IE1 and CMV promoter in 
luciferase assays in different cell lines. The relative luciferase activity was 
expressed as fold activity 24 h post-transfection, and the data were from three 
transfections. The transfections were performed with the reporter plasmid phRL with 
WSSV IE1, CMV and SV40 promoter individually. CEF: transfections in chicken 
embryo fibroblasts; SF9: transfections in SF9 cells. Vero: transfections in Vero cells. 
p. value is less than 0.005,  when WSSV ie promoter was compared with CMV 











5.4.2 WSSV IE1 promoter stimulates strong H5 hemagglutinin expression in 
baculovirus. 
To further compare WSSV IE1 promoter with CMV promoter in the 
efficiency of protein expression, four recombinant baculoviruses were constructed, 
termed as vAc-ie-HA and vAc-CMV-HA expressing HA; vAc-G-ie-HA and vAc-G-
CMV-HA coexpressing VSV G protein with HA for gene transduction (Bailey et al., 
1989; Mangor et al., 2001) (Fig 18). To confirm the activity of WSSV IE1 promoter 
in SF9 cells as shown in luciferase test, SF9 cells were infected with the four 
recombinant baculoviruses individually. The infected cells were fixed and subjected 
to antibody staining 3 days postinfection. 3D4 and 8B6 are two different H5-specific 
monoclonal antibodies used in these studies (He et al., 2007). As shown in Fig 3A, 
indirect fluorescence signals from HA protein were strong and sharp by recombinant 
baculoviruses with WSSV IE1 promoter. HA expression was detected in cells 
infected with CMV promoter-controlled baculoviruses though the fluorescence 
signals were diffused and faded. For those baculoviruses with VSV G cassette, the 
staining with anti-VSVG antibody verified the successful coexpression of VSV G 
protein and suggested the selected promoter has no effect on the infection efficiency 
(Fig. 19A).  
Baculovirus-expressed HA sustains hemagglutination activity. The HA titer of 
baculoviruses under different promoters was evaluated with the same number of virus 
particles. 25 µl of baculovirus at a titer of 1010 PFU/ml was used in the standard 
hemagglutination assay. Data were collected from 4 parallel assays. As shown in 
Figure 3B, constructs under WSSV IE1 promoter gave a higher mean 
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hemagglutination titer of 1:256 (vAc-ie-HA) to 1:320 (vAc-G-ie-HA), while those 
under CMV were at a mean titer of 1:44 (vAc-CMV-HA) to1:48 (vAc-G-CMV-HA) 
(p<0.05). Coexpression of VSV G protein had no significant effect on the 
hemagglutination result (p≥0.359). Besides, at a mean titer of 1:112, vAc-pol-HA, a 
HA-expressing construct under baculovirus polyhedrin promoter, was included in this 
hemagglutination test as a system control, since it is widely used in recombinant 
baculoviruses for HA production (Yang et al., 2007). The HA titer of vAc-ie-HA was 
higher than vAc-pol-HA at the same virus copies (p<0.0001), indicating its advantage 
in HA production. 
To verify this result, recombinant virus copies and HA contents were 
measured in a time course study during baculovirus infection. As shown in Fig.3C, 
the temporal kinetics of the growth curves for these viruses were similar (Lu, Yu, and 
Kwang, 2007) among the three promoters studied here. However, differences were 
found in HA production with the three promoters (Fig. 19D). With WSSV IE1 
promoter, the HA content in virions was up to 6.6 ug/ml (SD 0.56) corresponding to 
the virus titer of 109 PFU/ml at 96h post-infection. The HA content of polyhedrin 
promoter was 5.05 ug/ml (SD 0.48) at the similar virus titer, while the HA production 
of CMV promoter was around 2 ug/ml (SD 0.40) at the same collection time. In 
ANOVA test, p values for comparisons among three promoters at each time point 
were less than 0.005 and the differences between each two groups were considered as 
significant. (For N tests, p<0.005 is significant at the overall 0.05 level with 
Bonferroni adjustment.) Taken together, these results indicated that WSSV IE1 
promoter can induce more abundant H5 hemagglutinin expression in baculovirus with 
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Fig. 18 Schematic representation of the construction of variant baculoviruses in 
the study. The HA expression cassettes was inserted under different promoter 
individually. The desired VSV G expression cassettes was inserted under the 
polyhedrin promoter. ie: WSSV IE1 promoter; CMV: CMV promoter; pol: 
Polyhedrin promoter; G: VSV G protein; polyhedrin locus is based on pFast-1 












Fig. 19 Efficient production of activated HA protein of influenza virus by WSSV 
IE1 promoter in baculovirus. (A) Immunofluorescence assays with different 
recombinant baculovirus infected SF9 cells. Cells were fixed 3 days post-infection 
and subjected to antibody staining. 3D4 and 8B6 are H5-specific monoclonal 
antibodies. Anti-VSVG is anti-VSV G protein antibody. (B) Hemagglutination assays. 
Every 25 µl of baculovirus at a titer of 1010 PFU/ml was loaded into the standard 
hemagglutination assay. Data were collected from 4 parallel assays. (C) One-step 
growth curves of baculoviruses under three different promoters in SF9 cells. Each 
data point represents the mean value of four individual infections. SF9 cells were 
infected by individual viruses with a MOI of 0.5 PFU/cell. (D) HA contents of 
baculoviruses under three different promoters during infection. Data, shown in mean 





































































5.4.3 Immunogenicity of H5 hemagglutinin expressed by WSSV IE1 promoter in 
chickens  
The immunogenicity of baculovirus under WSSV IE1 promoter or CMV 
promoter was subsequently investigated through intramuscular (IM) or intranasal 
immunization (IN) of 2-week-old chickens with purified live virions without adjuvant. 
The live H5N1 vaccine (VNH5N1-PR8/CDC-RG) was used as the positive control, 
while PBS vaccinated chickens served as negative controls. The same H5N1 
(VNH5N1-PR8/CDC-RG) strain was inactivated with BEI (binary ethylenimine) 
(King, 1991) as another control. The serology assays performed here were based on 
five different serum samples from five individual chickens in the each group (95% 
confidence interval is between 8.72 and 35.02). To determine the neutralizing 
antibody level in those chicken sera, HI tests were performed with H5N1 (VNH5N1-
PR8/CDC-RG). As shown in Table 1, the WSSV IE1-type baculoviruses elicit higher 
HI titer than CMV promoter in serum samples. Coexpression of VSV G also 
contributes to an increase in anti-HA antibody level with HI activity. In addition, to 
confirm this result about the neutralization activity, a standard micro-neutralization 
test was performed with H5N1 (VNH5N1-PR8/CDC-RG) in MDCK cells. The sera 
induced by WSSV IE1-controlled HA-displaying baculoviruses showed a higher 
neutralization titer than those from CMV promoter, while coexpression of VSV G 
protein enhanced the neutralization titer in samples of both WSSV IE1 and CMV 
promoters. Further, serum samples were tested in ELISA. Serum samples from the 
second collection were diluted at 100 fold in PBS and tested for the anti-HA antibody 
level. For those samples from intramuscular injection (Fig.20A), at the same dosage 
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of virus inoculated, the chickens immunized with those baculoviruses under WSSV 
IE1 promoter developed higher antibody response than those under CMV promoter 
(p<0.05). Moreover, coexpression of VSV G protein contributed to an increase in 
anti-H5 antibody level (p<0.05) due to the transduction mediated by VSV G protein. 
In the lack of constant virus replication in vivo, antibody levels of these WSSV IE1 
baculovirus immunized chickens were relatively lower than those of live H5N1 
(VNH5N1-PR8/CDC-RG) infected chickens (p≤0.09), but they were higher than 
those of immunized chickens with inactivated H5N1 (VNH5N1-PR8/CDC-RG) at the 
same protein dosage (p<0.05). For those intranasally immunized chickens by 
baculovirus, lower IgG response was detected compared with intramuscularly 
injected chickens (Fig. 20B). Furthermore, cut-off value of this ELISA was 
determined as 0.3 based on tests with healthy new-born chicken serum. To further 
evaluate the HA-specific antibody level in sera, the dilution factor of each serum 
sample was recorded (Table 1) at the value beyond 0.3 in ELISA. The data obtained 
in this method is consistent to the results from other tests performed here. All of these 
findings indicated that efficient production of HA by WSSV IE1 promoter in 
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Table 1 Elicitation of influenza A virus HA specific antibody in chickens immunized 







































































Fig. 20 Immunogenicity of HA-expressing baculoviruses. (A,) ELISA antibody 
levels in chicken induced by various immunogens via intramuscular infection. (B) 
ELISA antibody levels induced by various immunogens via intranasal inoculation. 
Each group (n=5) of chickens were immunized with different vaccines at the same 
dose of virus particles or protein contents. Two weeks after the second vaccination, 
serum samples from individual chickens in each group were tested by ELISA with 
purified virion of H5N1 (VNH5N1-PR8/CDC-RG) as antigen. The results are 
expressed as the absorbance of 1:100 diluted individual sera at OD490. (C) 
Immunohistochemistry with frozen tissue sections from vaccinated chickens. Thymus 
was collected from intramuscularly immunized chickens and lung was collected from 





5.4.4 Significant antigen expression in chicken tissue was induced by HA-VSV G 
coexpression constructs 
To further study HA-transduction in immunized chickens and detect antigen 
expression in tissue based on vaccination, immunohistochemistry of frozen tissue 
sections from chickens was performed with an H5-specfic monoclonal antibody 2 
weeks after the second vaccination. Four chickens of each group were tested. Similar 
results were found among 3 chickens in the group of vAc-G-ie-HA by IM, 4 of vAc-
G-ie-HA by IN, 3 of vAc-G-CMV-HA by IM and 2 of vAc-G-CMV-HA by IN. In 
both of the two promoter groups, signals were mainly observed in the lung tissues 
(intranasal inoculation) and thymus tissues (intramuscular inoculation). As shown in 
Fig 20C, in frozen tissue sections from chickens inoculated with recombinant HA-
expressing baculovirus under WSSV IE1 promoter (vAc-G-ie-HA), signals of HA 
expression appeared intensive and distributed densely. In tissues from chickens 
inoculated with recombinant baculovirus vAc-G-CMV-HA, sporadic signals for HA 
expression were observed. These results gave direct evidence of successful protein 
transduction by VSV G-expressing baculoviruses. In addition, the recombinant 
baculovirus under WSSV IE1 promoter was shown to bring strong antigen expression 
in chicken tissues, which depends on its activity of HA expression in both of insect 








The recombinant baculoviruses under WSSV IE1 promoter presented here, 
present advantages in HA production and gene transduction, relying on its promoter 
efficiency in both vertebrate and invertebrate species. In this study, CMV promoter 
was used for major comparison because it displayed activity in both mammalian and 
insect cells as indicated in luciferase assays and it is widely used for protein 
expression and gene transduction in numerous cell lines (Lo et al., 2002; Ping et al., 
2006; Wang et al., 2007). However, CMV promoter might be relatively weak for 
protein expression in insect cells. Therefore, WSSV IE1 promoter was also compared 
with polyhedrin promoter from baculovirus in HA expression in insect cells. The 
results confirmed the role of WSSV IE1 promoter as an efficient promoter for 
baculovirus mediated protein expression. HA expressed in baculovirus served as 
exogenous antigen to stimulate primary immune response, while HA de novo 
expression in chicken tissue will contribute to the trigger of new HA-antibody 
production for further protection in a long run [18, 20]. For gene transduction, 
although CMV promoter is stronger in chicken cells than WSSV IE1 promoter, as 
indicated in luciferase assays, such advantage could be offset by the stronger HA 
expression on viral surface with WSSV IE1 promoter, which eventually leads to 
enhanced HA-specific immune response in chickens (Gao et al., 2007).  
To further verify those advantages brought by WSSV IE1 promoter in vaccine 
production, the immunogenicity of these baculovirus-based immunogens was studied 
with chickens. In the comparison of different promoters in the same type of 
baculovirus construct, vaccine dose was based on virus copies rather than protein 
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contents in order to differentiate the HA production efficiency by different promoters 
with the same amount of baculovirus copies (109 PFU) (Yang et al., 2007). As shown 
here, at the same dosage of baculovirus, constructs with WSSV IE1 promoter elicited 
better immune response than CMV promoter, confirming the higher HA expression 
level by WSSV IE1 promoter. Meanwhile, when the comparison was performed 
between baculovirus and attenuated H5N1 influenza virus, dosage was based on HA 
contents (6ug) due to differences in viral property. 
As the direct evidence for gene transduction, HA antigen expression in tissues 
was revealed in IHC assays. The results were repeatedly observed in most chickens 
from each group and considered to be significant. For intranasal inoculation, lung is 
the major organ to directly contact immunogen upon vaccination, where VSV G 
mediates virus entry and HA expresses with its individual promoter. Also, as the 
major organ involved in immunity of avian species, thymus supports exogenous 
antigen expression (Miller, 1990; Miller, 1994; Sharma, 1999). Therefore, for 
intramuscular injections, most of HA expression was detected in chicken thymus. 
Although baculovirus-expressed hemagglutinin influenza vaccines have been widely 
used and well characterized in different ways and under variant vector designs 
(Swayne et al., 2000; Treanor et al., 2006; Treanor et al., 2007; Treanor et al., 2001; 
Yang et al., 2007),  innovative methods are under investigation for more efficient HA 
production at a higher hemagglutination titer. WSSV IE1 promoter supports the 
abundant production of HA in baculovirus system, as compared with other promoters 
tested here. This allows it to induce higher level of specific antibody response in 
immunized poultries at the same number of baculovirus copies. In addition, compared 
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with inactivated H5 influenza virus vaccines at the same dose of HA protein (p<0.05), 
data shown here indicates that WSSV IE1 promoter-mediated baculovirus vaccine 
could present better immunogenicity without biosafety concerns in vaccine 
preparation (Takada et al., 1999). This also suggests that there could be some other 
properties of WSSV IE1-controlled baculovirus contributing to better 
immunogenicity. One possibility is that the surface-displayed HA in baculovirus 
sustains its natural conformation upon vaccination due to the obviation of the 
inactivation process in the baculovirus-type vaccine production (Yang et al., 2007). 
Future studies will focus to identify whether other properties of WSSV IE1 promoter 
support strong immunogenicity. Taken together, our studies provide an alternative 
choice for the efficient production of surface-displayed HA with baculovirus. Its 
vaccine potential was primarily studied in chickens, which might throw light on its 
promising trials in humans. 
The conculsion drawn from this studies indicates that with WSSV IE1 
promoter, the recombinant baculovirus provided an efficient and expeditious method 
in vaccine production, compared with traditional means. WSSV IE1 promoter-
mediated baculovirus conferred better immunogenicity in chickens upon vaccination 
in the light of the efficient HA expression in both insect and chicken cells. This study 
fully characterized the capacity of baculovirus featuring WSSV IE1 promoter in 
antigen production and immune response elicitation in chickens, suggesting it could 





































6.1 On the roles of RING proteins in WSSV 
During the last two decades, white spot syndrome virus has become one of the 
major threats to shrimp aquaculture causing massive death due to a combination of 
poor management practices and intensive culturing of penaeid shrimp. Since WSSV 
has a large genome of over 300 kbp and most of its ORFs do not have any 
homologues in Genebank, it is a major challenge to identify regulatory proteins of 
WSSV and to determine their functions (Escobedo-Bonilla et al., 2008; Leu et al., 
2009; van Hulten et al., 2001a). As shown in the studies presented here, identification 
of key proteins in WSSV by functional domains provides an effective solution to this 
problem. Considering the significance of RING domains in ubiquitination and other 
cellular functions, my research began with RING-H2 domains in WSSV. Together 
with the results from host-based yeast two hybrid assays, the demonstration of E3 
activity in these WSSV RING proteins reveals several different infection mechanisms 
of WSSV in shrimp. Similar to other DNA viruses, such as baculovirus, WSSV 
employs viral E3 ligases to inhibit host proteins or to hijack cellular ubiquitination 
components, indicating a conserved mechanism against host defence for successful 
virus infection and replication. In virus-mediated ubiquitination, viral E3 ligases 
sometimes employ host ubiquitination components to down-regulate specific host 
proteins via degradation. At the same time, this effect could further hamper normal 
ubiquitination in hosts due to the insufficient supply of E1s and E2s. In WSSV, the 
typical examples for these regulations are WSSV222 and WSSV249 (Wang et al., 
2005). WSSV222 can ubiquitinate and degrade TSL using the host ubiquitination 
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systems for successful virus replication, while WSSV249 sequesters different host 
E2s to promote virus-mediated ubiquitination. These functions of the two WSSV 
RING-containing  E3s are not contradictory. Both proteins employ host 
ubiquitination compontents to maintain intrinsic virus functions essential for 
successful virus infection, replication and release, though the target of each in 
ubiquitination could be different. On the other hand, in viruses carrying large 
genomes like WSSV, genes with similar important functions coexist to counteract 
possible genetic instability. If one gene is mutated by environmental factors, another 
one could continue to excercise its function and maintain stability in the virus (Yang 
et al., 2001). Therefore, WSSV have 4 RING containing proteins, which could 
prevent any loss in viral E3 function caused by genome mutations. The specific 
function of each WSSV RING protein will be studied in future WSSV research and 
will definitely extend our understanding of ubiquitin- mediated viral  regulation. 
(Wang et al., 2008a) 
Overall, this study promotes the understanding of WSSV itself and sheds light 
on the significance of ubiquitin-mediated regulation in invertebrate species. 
Furthermore, my work provides promising solutions for the treatment of white spot 





6.2 In the light of new findings 
A recent study has indicated that the E3 ubiquitin ligase WSSV249 from 
WSSV employs a low E2 specificity to disturb the balance of the ubiquitin-26S 
proteasome pathway, leading to viral pathogenesis in shrimp (unpublished data). 
These findings further elucidate a novel mechanism employed by WSSV RINGs to 
promote viral pathogenesis via ubiquitination, which enlightens researchers on new 
models of ubiquitin-involved regulation in WSSV. 
Another interesting report on OVCA1, the human orthologue of TSL, has 
revealed that it is a candidate gene of the genetic modifier of Tp53, Mop2 and affects 
mouse embryonic lethality. OVCA1 could be used as a model to reveal the regulatory 
pathway downstream of shrimp TSL. Further information acquired by studying 
OVCA1 will certainly bring new perspectives to TSL function, deepening our 
understanding of shrimp immunity, as well as of WSSV inhibition (Liang et al., 2008).  
More regulatory proteins in WSSV have been identified and characterized in recent 
years employing new technologies. For example, white spot syndrome virus (WSSV) 
IE genes were identified recently with cycloheximide (CHX)-treated primary culture 
of crayfish hemocytes and a WSSV genome tiling microarray (Li et al., 2009). 
Besides, the mechanism of WSSV virion formation by the four major structural 
proteins (Chang et al., 2008; Wan, Xu, and Yang, 2008; Zhou et al., 2009) was 
discovered by far western blot and mass spectrometry studies. In the light of these 
methodological advances in WSSV research, studies of the ubiquitination-mediated 
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6.3 That which remains 
Viruses have evolved to use cellular pathways to their advantage, including 
the ubiquitin-proteasome pathway of protein degradation. The findings presented here 
have verified the model in which viral proteins act as E3 ligases to permit the targeted 
degradation of proteins to enhance the efficiency of virus replication. Besides, there 
are alternative regulatory mechanisms employed by viruses. In several cases, viruses 
produce proteins that highjack cellular E3 ligases to modify their substrate specificity 
in order to eliminate unwanted cellular proteins, in particular inhibitors of the cell 
cycle (Boutell and Everett, 2003; Chen and Gerlier, 2006; Liu et al., 2007). For 
example, HPV E6 mediates the degradation of p53 by using cellular E6AP as an E3 
ligase. Furthermore, some cellular E3 ligases are inhibited by viral proteins to prevent 
specific protein degradation and viruses even use the ubiquitination system to control 
the expression level of their own proteins, such as SV40 large T antigen (Blanchette 
and Branton, 2009). In WSSV, which contains a large genome of 300kbp, it is highly 
possible that there could be other proteins involved in the ubiquitin-proteasome 
pathway, besides the RING proteins described here. Among the RING proteins in 
WSSV, the function of WSSV403 has not been fully characterized and the role of 
WSSV199 is not known yet. Containing a RING domain, these viral proteins could 
potentially recruit ubiquitination components either to mediate degradation of viral 
inhibitors or to block the binding sites of cellular E3 ligases. 
In addition to having functional RING domains, posttranslational 
modifications and changes in the expression levels can be crucial factors in 
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determining viral E3 activity. For example, phosphorylation of some IAPs, which act 
as E3s, affects intracellular localization. Interaction between the shrimp phosphatase 
and WSSV403 suggests that shrimp could regulate WSSV RING proteins via changes 
in the phosphorylation state of viral proteins. 
The study of shrimp viruses has been hampered by the lack of a reliable and 
convenient in vitro cell culture system (Tapay et al., 1997). A previous report (Hsu, 
1995) claimed development of a cell line,“PMO,” from shrimp lymphoid organ. 
However, increasing doubts on the true origin of the “PMO” cell line prompted us to 
carry out a sequence analysis using “PMO” DNA as a template and universal primers 
5 -CGCCTGTTTAACAAAAACAT-  3  and 5 -
CCGGTCTGAACTCAGATCATGT- 3  for shrimp mitochondrial 16S rRNA 
(Bouchen, 1994) in a PCR analysis. Sequence analysis of the PCR product showed 
that the “PMO” cell line 16S rRNA shares 100% homology with Anguilla japonica 
mitochondrial 16S rRNA (data not shown), which led us to conclude that “PMO” is 
actually derived from Anguilla japonica, a species of eel. Therefore, primary cell 
cultures from shrimps have been employed for WSSV studies. Several investigators 
have reported on the successful development of WSSV-infected primary cultures 
from lymphoid organs from Penaeus monodon (Kasomchandra, 1999; Wang, 2000), 
the blue shrimp, Litopenaeus stylirostris (Tapay et al., 1997), and the kuruma shrimp, 
Marsupenaeus japonicus (Itami, 1999). Primary shrimp cell cultures were also 
developed from ovaries of black tiger shrimp, P. monodon (Kasomchandra, 1999), 
and the use of primary ovarian cultures of the kuruma shrimp, Marsupenaeus 
japonicus, was reported to facilitate characterization of WSSV infection (Maeda et al., 
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2004). In this study, we developed primary cell cultures from the lymphoid organs of 
P. vannamei and used them for indirect fluorescent-antibody studies. The 
establishment of a continuous shrimp cell line thus remains a challenge for shrimp 
virus research. 
Pending the development of a study platform in shrimp cells, further 
clarification and characterization of these WSSV RINGs and other regulatory proteins 
will certainly throw light on the viral ubiquitination pathways and improve the 
understanding of the WSSV infection machinery as well as the invertebrate immune 
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